Medication,Common route(s),Typical adult dose / range,Typical frequency,Peds (Neonate 0–28d) dose; freq,Peds (Infant 1–12mo) dose; freq,Peds (Child 1–12y) dose; freq,Peds (Adolescent 12–18y) dose; freq,Renal adjustment (adult/peds),Hepatic adjustment (adult/peds),IV Fluid options,Standard rates (mL/h 10–200),Weight-based maintenance (adult),Peds maintenance (4-2-1 rule),Weight (kg) – enter to auto-calc,Adult maint mL/h @1.0 mL/kg/h,Adult maint mL/h @1.5 mL/kg/h,Adult maint mL/h @2.0 mL/kg/h,Peds 4-2-1 mL/h (auto),Sepsis bolus mL @30 mL/kg
Ceftriaxone,IV,1–2 g IV q24h (meningitis: 2 g IV q12h),q24h (q12h for meningitis),—,—,50–75 mg/kg IV q24h (max 2 g); meningitis 100 mg/kg/day divided q12h (max 4 g),50 mg/kg IV q24h (max 2 g); meningitis 2 g q12h,No renal adj (non-dialysis); give post-HD; avoid in severe hyperbilirubinemic neonates,Caution in severe hepatic impairment,,,,,,"=IF(ISBLANK($O2), """", $O2*1.0)","=IF(ISBLANK($O2), """", $O2*1.5)","=IF(ISBLANK($O2), """", $O2*2.0)","=IF(ISBLANK($O2), """", 4*MIN(10,$O2) + 2*MAX(0,MIN(10,$O2-10)) + 1*MAX(0,$O2-20))","=IF(ISBLANK($O2), """", $O2*30)"
Cefepime,IV,1–2 g IV q8–12h (CrCl adjust),q8–12h,—,—,50 mg/kg IV q8–12h (max 2 g/dose),50 mg/kg IV q8–12h (max 2 g/dose),Adjust if CrCl <60 mL/min; extend interval,No routine adjustment,,,,,,"=IF(ISBLANK($O3), """", $O3*1.0)","=IF(ISBLANK($O3), """", $O3*1.5)","=IF(ISBLANK($O3), """", $O3*2.0)","=IF(ISBLANK($O3), """", 4*MIN(10,$O3) + 2*MAX(0,MIN(10,$O3-10)) + 1*MAX(0,$O3-20))","=IF(ISBLANK($O3), """", $O3*30)"
Piperacillin‑tazobactam,IV,3.375–4.5 g IV q6–8h (extended infusion common),q6–8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O4), """", $O4*1.0)","=IF(ISBLANK($O4), """", $O4*1.5)","=IF(ISBLANK($O4), """", $O4*2.0)","=IF(ISBLANK($O4), """", 4*MIN(10,$O4) + 2*MAX(0,MIN(10,$O4-10)) + 1*MAX(0,$O4-20))","=IF(ISBLANK($O4), """", $O4*30)"
Ampicillin‑sulbactam,IV,1.5–3 g IV q6h,q6h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O5), """", $O5*1.0)","=IF(ISBLANK($O5), """", $O5*1.5)","=IF(ISBLANK($O5), """", $O5*2.0)","=IF(ISBLANK($O5), """", 4*MIN(10,$O5) + 2*MAX(0,MIN(10,$O5-10)) + 1*MAX(0,$O5-20))","=IF(ISBLANK($O5), """", $O5*30)"
Amoxicillin‑clavulanate,PO,875/125 mg PO q12h or 500/125 mg q8h,q8–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O6), """", $O6*1.0)","=IF(ISBLANK($O6), """", $O6*1.5)","=IF(ISBLANK($O6), """", $O6*2.0)","=IF(ISBLANK($O6), """", 4*MIN(10,$O6) + 2*MAX(0,MIN(10,$O6-10)) + 1*MAX(0,$O6-20))","=IF(ISBLANK($O6), """", $O6*30)"
Nafcillin,IV,2 g IV q4h (or 3 g IV q6h),q4–6h,—,—,100–200 mg/kg/day IV divided q6h,2 g IV q4–6h (adolescent adult-like),No renal adj; not dialyzable,Caution hepatic dysfunction; monitor LFTs,,,,,,"=IF(ISBLANK($O7), """", $O7*1.0)","=IF(ISBLANK($O7), """", $O7*1.5)","=IF(ISBLANK($O7), """", $O7*2.0)","=IF(ISBLANK($O7), """", 4*MIN(10,$O7) + 2*MAX(0,MIN(10,$O7-10)) + 1*MAX(0,$O7-20))","=IF(ISBLANK($O7), """", $O7*30)"
Oxacillin,IV,2 g IV q4h,q4h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O8), """", $O8*1.0)","=IF(ISBLANK($O8), """", $O8*1.5)","=IF(ISBLANK($O8), """", $O8*2.0)","=IF(ISBLANK($O8), """", 4*MIN(10,$O8) + 2*MAX(0,MIN(10,$O8-10)) + 1*MAX(0,$O8-20))","=IF(ISBLANK($O8), """", $O8*30)"
Cefazolin,IV,1–2 g IV q8h (surgical prophylaxis 2 g once pre‑op; 3 g if >120kg),q8h,—,25–50 mg/kg/day IV divided q8h,50–100 mg/kg/day IV divided q8h (max 2 g/dose),25–50 mg/kg IV q8h (max 2 g/dose),Adjust if CrCl <50; post-HD dosing,No routine adjustment,,,,,,"=IF(ISBLANK($O9), """", $O9*1.0)","=IF(ISBLANK($O9), """", $O9*1.5)","=IF(ISBLANK($O9), """", $O9*2.0)","=IF(ISBLANK($O9), """", 4*MIN(10,$O9) + 2*MAX(0,MIN(10,$O9-10)) + 1*MAX(0,$O9-20))","=IF(ISBLANK($O9), """", $O9*30)"
Ceftazidime,IV,2 g IV q8h,q8h,—,—,50 mg/kg IV q8h (max 2 g/dose),50 mg/kg IV q8h (max 2 g/dose),Adjust if CrCl <50; post-HD dosing,No routine adjustment,,,,,,"=IF(ISBLANK($O10), """", $O10*1.0)","=IF(ISBLANK($O10), """", $O10*1.5)","=IF(ISBLANK($O10), """", $O10*2.0)","=IF(ISBLANK($O10), """", 4*MIN(10,$O10) + 2*MAX(0,MIN(10,$O10-10)) + 1*MAX(0,$O10-20))","=IF(ISBLANK($O10), """", $O10*30)"
Meropenem,IV,1 g IV q8h (meningitis 2 g q8h),q8h,—,20–40 mg/kg IV q8–12h (meningitis 40 mg/kg q8h),20–40 mg/kg IV q8h (max 2 g/dose),20–40 mg/kg IV q8h (max 2 g/dose),Adjust if CrCl <50; post-HD dosing,No routine adjustment,,,,,,"=IF(ISBLANK($O11), """", $O11*1.0)","=IF(ISBLANK($O11), """", $O11*1.5)","=IF(ISBLANK($O11), """", $O11*2.0)","=IF(ISBLANK($O11), """", 4*MIN(10,$O11) + 2*MAX(0,MIN(10,$O11-10)) + 1*MAX(0,$O11-20))","=IF(ISBLANK($O11), """", $O11*30)"
Ertapenem,IV,1 g IV q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O12), """", $O12*1.0)","=IF(ISBLANK($O12), """", $O12*1.5)","=IF(ISBLANK($O12), """", $O12*2.0)","=IF(ISBLANK($O12), """", 4*MIN(10,$O12) + 2*MAX(0,MIN(10,$O12-10)) + 1*MAX(0,$O12-20))","=IF(ISBLANK($O12), """", $O12*30)"
Imipenem‑cilastatin,IV,500 mg IV q6h (CrCl adjust),q6h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O13), """", $O13*1.0)","=IF(ISBLANK($O13), """", $O13*1.5)","=IF(ISBLANK($O13), """", $O13*2.0)","=IF(ISBLANK($O13), """", 4*MIN(10,$O13) + 2*MAX(0,MIN(10,$O13-10)) + 1*MAX(0,$O13-20))","=IF(ISBLANK($O13), """", $O13*30)"
Aztreonam,IV,1–2 g IV q8h,q8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O14), """", $O14*1.0)","=IF(ISBLANK($O14), """", $O14*1.5)","=IF(ISBLANK($O14), """", $O14*2.0)","=IF(ISBLANK($O14), """", 4*MIN(10,$O14) + 2*MAX(0,MIN(10,$O14-10)) + 1*MAX(0,$O14-20))","=IF(ISBLANK($O14), """", $O14*30)"
Vancomycin,IV,15–20 mg/kg IV q8–12h (AUC‑guided; load 20–25 mg/kg),q8–12h,10–15 mg/kg IV q12h (AUC-guided),15 mg/kg IV q6–8h,15 mg/kg IV q6–8h (AUC-guided),15–20 mg/kg IV q8–12h (AUC-guided),Adjust to AUC/levels; extend interval as CrCl falls; post-HD dosing,No routine adjustment,,,,,,"=IF(ISBLANK($O15), """", $O15*1.0)","=IF(ISBLANK($O15), """", $O15*1.5)","=IF(ISBLANK($O15), """", $O15*2.0)","=IF(ISBLANK($O15), """", 4*MIN(10,$O15) + 2*MAX(0,MIN(10,$O15-10)) + 1*MAX(0,$O15-20))","=IF(ISBLANK($O15), """", $O15*30)"
Daptomycin,IV,4–10 mg/kg IV q24h (indication‑dependent),q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O16), """", $O16*1.0)","=IF(ISBLANK($O16), """", $O16*1.5)","=IF(ISBLANK($O16), """", $O16*2.0)","=IF(ISBLANK($O16), """", 4*MIN(10,$O16) + 2*MAX(0,MIN(10,$O16-10)) + 1*MAX(0,$O16-20))","=IF(ISBLANK($O16), """", $O16*30)"
Linezolid,"IV, PO",600 mg IV/PO q12h,q12h,—,10 mg/kg IV/PO q8h (≤11y),10 mg/kg IV/PO q8h (≤11y),600 mg q12h (≥12y),No adjustment; monitor for accumulation in severe failure,No routine adjustment; caution severe hepatic impairment,,,,,,"=IF(ISBLANK($O17), """", $O17*1.0)","=IF(ISBLANK($O17), """", $O17*1.5)","=IF(ISBLANK($O17), """", $O17*2.0)","=IF(ISBLANK($O17), """", 4*MIN(10,$O17) + 2*MAX(0,MIN(10,$O17-10)) + 1*MAX(0,$O17-20))","=IF(ISBLANK($O17), """", $O17*30)"
Clindamycin,"IV, PO",600–900 mg IV q8h or 300–450 mg PO q6–8h,q6–8h,—,10–13 mg/kg IV q8h (PO 10 mg/kg q8h),10 mg/kg IV/PO q6–8h (max 600 mg/dose IV; 450 mg/dose PO),10 mg/kg IV/PO q6–8h (max adult doses),No renal adjustment,Caution severe hepatic impairment; extend interval,,,,,,"=IF(ISBLANK($O18), """", $O18*1.0)","=IF(ISBLANK($O18), """", $O18*1.5)","=IF(ISBLANK($O18), """", $O18*2.0)","=IF(ISBLANK($O18), """", 4*MIN(10,$O18) + 2*MAX(0,MIN(10,$O18-10)) + 1*MAX(0,$O18-20))","=IF(ISBLANK($O18), """", $O18*30)"
Levofloxacin,"IV, PO",500–750 mg IV/PO q24h,q24h,—,—,10–20 mg/kg/day divided q12–24h (use restricted; max 750 mg/day),10 mg/kg q24h (max 750 mg),Adjust if CrCl <50,No routine adjustment,,,,,,"=IF(ISBLANK($O19), """", $O19*1.0)","=IF(ISBLANK($O19), """", $O19*1.5)","=IF(ISBLANK($O19), """", $O19*2.0)","=IF(ISBLANK($O19), """", 4*MIN(10,$O19) + 2*MAX(0,MIN(10,$O19-10)) + 1*MAX(0,$O19-20))","=IF(ISBLANK($O19), """", $O19*30)"
Ciprofloxacin,"IV, PO",400 mg IV q12h or 500–750 mg PO q12h,q12h,—,—,10–15 mg/kg/dose q12h (max 400 mg IV / 750 mg PO),Same as child; consider indication restrictions,Adjust if CrCl <50,No routine adjustment,,,,,,"=IF(ISBLANK($O20), """", $O20*1.0)","=IF(ISBLANK($O20), """", $O20*1.5)","=IF(ISBLANK($O20), """", $O20*2.0)","=IF(ISBLANK($O20), """", 4*MIN(10,$O20) + 2*MAX(0,MIN(10,$O20-10)) + 1*MAX(0,$O20-20))","=IF(ISBLANK($O20), """", $O20*30)"
Metronidazole,"IV, PO",500 mg IV/PO q8h,q8h,—,7.5 mg/kg q6–8h,7.5–10 mg/kg q6–8h (max 500 mg/dose),7.5 mg/kg q6–8h (max adult doses),No adjustment; consider post-HD dose,Reduce dose/extend interval in severe hepatic impairment,,,,,,"=IF(ISBLANK($O21), """", $O21*1.0)","=IF(ISBLANK($O21), """", $O21*1.5)","=IF(ISBLANK($O21), """", $O21*2.0)","=IF(ISBLANK($O21), """", 4*MIN(10,$O21) + 2*MAX(0,MIN(10,$O21-10)) + 1*MAX(0,$O21-20))","=IF(ISBLANK($O21), """", $O21*30)"
TMP‑SMX,"IV, PO",1–2 DS tabs PO q12h or 8–12 mg/kg/day TMP IV divided q6–8h,q6–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O22), """", $O22*1.0)","=IF(ISBLANK($O22), """", $O22*1.5)","=IF(ISBLANK($O22), """", $O22*2.0)","=IF(ISBLANK($O22), """", 4*MIN(10,$O22) + 2*MAX(0,MIN(10,$O22-10)) + 1*MAX(0,$O22-20))","=IF(ISBLANK($O22), """", $O22*30)"
Acyclovir,IV,5–10 mg/kg IV q8h (HSV encephalitis 10 mg/kg),q8h,10–20 mg/kg IV q8h (HSV severe/encephalitis),10 mg/kg IV q8h,10 mg/kg IV q8h (max adult dose),Same as child (weight-based),Adjust for CrCl; aggressive hydration to reduce crystalluria,No adjustment,,,,,,"=IF(ISBLANK($O23), """", $O23*1.0)","=IF(ISBLANK($O23), """", $O23*1.5)","=IF(ISBLANK($O23), """", $O23*2.0)","=IF(ISBLANK($O23), """", 4*MIN(10,$O23) + 2*MAX(0,MIN(10,$O23-10)) + 1*MAX(0,$O23-20))","=IF(ISBLANK($O23), """", $O23*30)"
Oseltamivir,PO,75 mg PO q12h,q12h,—,3 mg/kg/dose q12h (≤15 kg) per weight bands,Weight-band dosing (30–60 mg q12h),75 mg q12h,Reduce if CrCl <60,No adjustment,,,,,,"=IF(ISBLANK($O24), """", $O24*1.0)","=IF(ISBLANK($O24), """", $O24*1.5)","=IF(ISBLANK($O24), """", $O24*2.0)","=IF(ISBLANK($O24), """", 4*MIN(10,$O24) + 2*MAX(0,MIN(10,$O24-10)) + 1*MAX(0,$O24-20))","=IF(ISBLANK($O24), """", $O24*30)"
Fluconazole,"IV, PO",200–400 mg IV/PO q24h (load 800 mg for candidemia),q24h,—,6 mg/kg load then 3–6 mg/kg q24h,6–12 mg/kg q24h (max adult doses),3–6 mg/kg q24h (max adult),Reduce maintenance if CrCl <50,No routine adjustment; monitor LFTs,,,,,,"=IF(ISBLANK($O25), """", $O25*1.0)","=IF(ISBLANK($O25), """", $O25*1.5)","=IF(ISBLANK($O25), """", $O25*2.0)","=IF(ISBLANK($O25), """", 4*MIN(10,$O25) + 2*MAX(0,MIN(10,$O25-10)) + 1*MAX(0,$O25-20))","=IF(ISBLANK($O25), """", $O25*30)"
Micafungin,IV,100 mg IV q24h (esoph. candida 150 mg),q24h,—,2–4 mg/kg q24h (NICU often 10 mg/kg for candidemia; institutional),2–4 mg/kg q24h (max adult doses),100 mg q24h (adult-like),No adjustment,No routine adjustment,,,,,,"=IF(ISBLANK($O26), """", $O26*1.0)","=IF(ISBLANK($O26), """", $O26*1.5)","=IF(ISBLANK($O26), """", $O26*2.0)","=IF(ISBLANK($O26), """", 4*MIN(10,$O26) + 2*MAX(0,MIN(10,$O26-10)) + 1*MAX(0,$O26-20))","=IF(ISBLANK($O26), """", $O26*30)"
Heparin (UFH) infusion,IV,Bolus 60–80 units/kg then 12–18 units/kg/h titrated by aPTT/anti‑Xa,Continuous,—,—,Initial 75 units/kg IV bolus then 20 units/kg/h infusion (protocol-driven),Protocol-driven adolescent dosing; anti-Xa goal based,No renal adj; monitor anti-Xa/aPTT,Caution severe hepatic disease (coagulopathy),,,,,,"=IF(ISBLANK($O27), """", $O27*1.0)","=IF(ISBLANK($O27), """", $O27*1.5)","=IF(ISBLANK($O27), """", $O27*2.0)","=IF(ISBLANK($O27), """", 4*MIN(10,$O27) + 2*MAX(0,MIN(10,$O27-10)) + 1*MAX(0,$O27-20))","=IF(ISBLANK($O27), """", $O27*30)"
Enoxaparin (therapeutic),SC,1 mg/kg SC q12h or 1.5 mg/kg q24h (CrCl adjust),q12–24h,—,1.5 mg/kg SC q12h (infants often q12h),1 mg/kg SC q12h (anti-Xa guided),1 mg/kg SC q12h,Adjust if CrCl <30; monitor anti-Xa,Caution hepatic impairment (bleeding risk),,,,,,"=IF(ISBLANK($O28), """", $O28*1.0)","=IF(ISBLANK($O28), """", $O28*1.5)","=IF(ISBLANK($O28), """", $O28*2.0)","=IF(ISBLANK($O28), """", 4*MIN(10,$O28) + 2*MAX(0,MIN(10,$O28-10)) + 1*MAX(0,$O28-20))","=IF(ISBLANK($O28), """", $O28*30)"
Enoxaparin (prophylaxis),SC,40 mg SC q24h (30 mg q12h ortho; 30 mg q24h if CrCl<30),q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O29), """", $O29*1.0)","=IF(ISBLANK($O29), """", $O29*1.5)","=IF(ISBLANK($O29), """", $O29*2.0)","=IF(ISBLANK($O29), """", 4*MIN(10,$O29) + 2*MAX(0,MIN(10,$O29-10)) + 1*MAX(0,$O29-20))","=IF(ISBLANK($O29), """", $O29*30)"
Warfarin,PO,2–5 mg PO daily then INR‑guided,Daily,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O30), """", $O30*1.0)","=IF(ISBLANK($O30), """", $O30*1.5)","=IF(ISBLANK($O30), """", $O30*2.0)","=IF(ISBLANK($O30), """", 4*MIN(10,$O30) + 2*MAX(0,MIN(10,$O30-10)) + 1*MAX(0,$O30-20))","=IF(ISBLANK($O30), """", $O30*30)"
Apixaban,PO,5 mg PO q12h (2.5 mg q12h if criteria met),q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O31), """", $O31*1.0)","=IF(ISBLANK($O31), """", $O31*1.5)","=IF(ISBLANK($O31), """", $O31*2.0)","=IF(ISBLANK($O31), """", 4*MIN(10,$O31) + 2*MAX(0,MIN(10,$O31-10)) + 1*MAX(0,$O31-20))","=IF(ISBLANK($O31), """", $O31*30)"
Rivaroxaban,PO,15 mg PO q12h ×21d then 20 mg q24h (VTE); AF 20 mg q24h,q12–24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O32), """", $O32*1.0)","=IF(ISBLANK($O32), """", $O32*1.5)","=IF(ISBLANK($O32), """", $O32*2.0)","=IF(ISBLANK($O32), """", 4*MIN(10,$O32) + 2*MAX(0,MIN(10,$O32-10)) + 1*MAX(0,$O32-20))","=IF(ISBLANK($O32), """", $O32*30)"
Clopidogrel,PO,75 mg PO q24h (ACS load 300–600 mg),q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O33), """", $O33*1.0)","=IF(ISBLANK($O33), """", $O33*1.5)","=IF(ISBLANK($O33), """", $O33*2.0)","=IF(ISBLANK($O33), """", 4*MIN(10,$O33) + 2*MAX(0,MIN(10,$O33-10)) + 1*MAX(0,$O33-20))","=IF(ISBLANK($O33), """", $O33*30)"
Aspirin,PO,81 mg PO q24h (pain 325–650 mg q4–6h),q24h (or q4–6h for analgesia),—,—,3–5 mg/kg/day (antiplatelet); avoid for fever (Reye risk),Antiplatelet 81 mg daily typical; avoid for viral febrile illness,Avoid in severe renal disease; monitor,Avoid in severe hepatic impairment,,,,,,"=IF(ISBLANK($O34), """", $O34*1.0)","=IF(ISBLANK($O34), """", $O34*1.5)","=IF(ISBLANK($O34), """", $O34*2.0)","=IF(ISBLANK($O34), """", 4*MIN(10,$O34) + 2*MAX(0,MIN(10,$O34-10)) + 1*MAX(0,$O34-20))","=IF(ISBLANK($O34), """", $O34*30)"
Amiodarone (IV),IV,150 mg IV over 10 min then 1 mg/min ×6h then 0.5 mg/min,Infusion,—,—,5 mg/kg IV load over 20–60 min; infusion 5–15 mcg/kg/min,Similar weight-based dosing,No renal adj,Caution severe hepatic impairment; reduce/monitor,,,,,,"=IF(ISBLANK($O35), """", $O35*1.0)","=IF(ISBLANK($O35), """", $O35*1.5)","=IF(ISBLANK($O35), """", $O35*2.0)","=IF(ISBLANK($O35), """", 4*MIN(10,$O35) + 2*MAX(0,MIN(10,$O35-10)) + 1*MAX(0,$O35-20))","=IF(ISBLANK($O35), """", $O35*30)"
Metoprolol tartrate,"PO, IV",12.5–50 mg PO q6–12h (IV 5 mg q5 min to total 15 mg),q6–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O36), """", $O36*1.0)","=IF(ISBLANK($O36), """", $O36*1.5)","=IF(ISBLANK($O36), """", $O36*2.0)","=IF(ISBLANK($O36), """", 4*MIN(10,$O36) + 2*MAX(0,MIN(10,$O36-10)) + 1*MAX(0,$O36-20))","=IF(ISBLANK($O36), """", $O36*30)"
Carvedilol,PO,3.125–25 mg PO q12h,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O37), """", $O37*1.0)","=IF(ISBLANK($O37), """", $O37*1.5)","=IF(ISBLANK($O37), """", $O37*2.0)","=IF(ISBLANK($O37), """", 4*MIN(10,$O37) + 2*MAX(0,MIN(10,$O37-10)) + 1*MAX(0,$O37-20))","=IF(ISBLANK($O37), """", $O37*30)"
Diltiazem (IV),IV,Bolus 0.25 mg/kg then 5–15 mg/h infusion,Infusion,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O38), """", $O38*1.0)","=IF(ISBLANK($O38), """", $O38*1.5)","=IF(ISBLANK($O38), """", $O38*2.0)","=IF(ISBLANK($O38), """", 4*MIN(10,$O38) + 2*MAX(0,MIN(10,$O38-10)) + 1*MAX(0,$O38-20))","=IF(ISBLANK($O38), """", $O38*30)"
Adenosine,IV,6 mg IV push; may repeat 12 mg,"Once, may repeat",—,—,"0.1 mg/kg IV rapid push (max 6 mg), may repeat 0.2 mg/kg (max 12 mg)",Same,No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O39), """", $O39*1.0)","=IF(ISBLANK($O39), """", $O39*1.5)","=IF(ISBLANK($O39), """", $O39*2.0)","=IF(ISBLANK($O39), """", 4*MIN(10,$O39) + 2*MAX(0,MIN(10,$O39-10)) + 1*MAX(0,$O39-20))","=IF(ISBLANK($O39), """", $O39*30)"
Norepinephrine,IV,0.01–0.5 mcg/kg/min titrated,Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O40), """", $O40*1.0)","=IF(ISBLANK($O40), """", $O40*1.5)","=IF(ISBLANK($O40), """", $O40*2.0)","=IF(ISBLANK($O40), """", 4*MIN(10,$O40) + 2*MAX(0,MIN(10,$O40-10)) + 1*MAX(0,$O40-20))","=IF(ISBLANK($O40), """", $O40*30)"
Epinephrine (anaphylaxis),IM,0.3–0.5 mg IM (1 mg/mL) may repeat q5–15 min,q5–15 min PRN,—,—,0.01 mg/kg IM (1 mg/mL) max 0.3 mg; repeat q5–15 min,0.3–0.5 mg IM (≥30 kg),No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O41), """", $O41*1.0)","=IF(ISBLANK($O41), """", $O41*1.5)","=IF(ISBLANK($O41), """", $O41*2.0)","=IF(ISBLANK($O41), """", 4*MIN(10,$O41) + 2*MAX(0,MIN(10,$O41-10)) + 1*MAX(0,$O41-20))","=IF(ISBLANK($O41), """", $O41*30)"
Phenylephrine,IV,0.1–5 mcg/kg/min titrated,Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O42), """", $O42*1.0)","=IF(ISBLANK($O42), """", $O42*1.5)","=IF(ISBLANK($O42), """", $O42*2.0)","=IF(ISBLANK($O42), """", 4*MIN(10,$O42) + 2*MAX(0,MIN(10,$O42-10)) + 1*MAX(0,$O42-20))","=IF(ISBLANK($O42), """", $O42*30)"
Nitroglycerin (IV),IV,5–200 mcg/min titrated,Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O43), """", $O43*1.0)","=IF(ISBLANK($O43), """", $O43*1.5)","=IF(ISBLANK($O43), """", $O43*2.0)","=IF(ISBLANK($O43), """", 4*MIN(10,$O43) + 2*MAX(0,MIN(10,$O43-10)) + 1*MAX(0,$O43-20))","=IF(ISBLANK($O43), """", $O43*30)"
Hydralazine,"IV, PO",10–20 mg IV q4–6h PRN,q4–6h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O44), """", $O44*1.0)","=IF(ISBLANK($O44), """", $O44*1.5)","=IF(ISBLANK($O44), """", $O44*2.0)","=IF(ISBLANK($O44), """", 4*MIN(10,$O44) + 2*MAX(0,MIN(10,$O44-10)) + 1*MAX(0,$O44-20))","=IF(ISBLANK($O44), """", $O44*30)"
Labetalol,"IV, PO",10–20 mg IV q10 min PRN or infusion 0.5–2 mg/min,PRN / infusion,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O45), """", $O45*1.0)","=IF(ISBLANK($O45), """", $O45*1.5)","=IF(ISBLANK($O45), """", $O45*2.0)","=IF(ISBLANK($O45), """", 4*MIN(10,$O45) + 2*MAX(0,MIN(10,$O45-10)) + 1*MAX(0,$O45-20))","=IF(ISBLANK($O45), """", $O45*30)"
Albuterol (nebulized),INH,2.5 mg neb q4–6h PRN (or 4–8 puffs MDI q20min ×3),q4–6h PRN,—,1.25–2.5 mg neb q4–6h PRN,2.5 mg neb q4–6h PRN (or by weight),2.5 mg neb q4–6h PRN,No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O46), """", $O46*1.0)","=IF(ISBLANK($O46), """", $O46*1.5)","=IF(ISBLANK($O46), """", $O46*2.0)","=IF(ISBLANK($O46), """", 4*MIN(10,$O46) + 2*MAX(0,MIN(10,$O46-10)) + 1*MAX(0,$O46-20))","=IF(ISBLANK($O46), """", $O46*30)"
Ipratropium (nebulized),INH,0.5 mg neb q6–8h,q6–8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O47), """", $O47*1.0)","=IF(ISBLANK($O47), """", $O47*1.5)","=IF(ISBLANK($O47), """", $O47*2.0)","=IF(ISBLANK($O47), """", 4*MIN(10,$O47) + 2*MAX(0,MIN(10,$O47-10)) + 1*MAX(0,$O47-20))","=IF(ISBLANK($O47), """", $O47*30)"
Methylprednisolone,IV,40–125 mg IV q6–12h (exacerbations),q6–12h,—,—,1–2 mg/kg/day divided q6–12h (status asthmaticus higher),0.5–1 mg/kg q6–12h (max adult),No adjustment,Caution hepatic impairment; monitor,,,,,,"=IF(ISBLANK($O48), """", $O48*1.0)","=IF(ISBLANK($O48), """", $O48*1.5)","=IF(ISBLANK($O48), """", $O48*2.0)","=IF(ISBLANK($O48), """", 4*MIN(10,$O48) + 2*MAX(0,MIN(10,$O48-10)) + 1*MAX(0,$O48-20))","=IF(ISBLANK($O48), """", $O48*30)"
Prednisone,PO,40–60 mg PO daily (taper per indication),Daily,—,—,1–2 mg/kg/day PO once daily (max adult),1 mg/kg/day (max adult),No adjustment,No adjustment (use caution),,,,,,"=IF(ISBLANK($O49), """", $O49*1.0)","=IF(ISBLANK($O49), """", $O49*1.5)","=IF(ISBLANK($O49), """", $O49*2.0)","=IF(ISBLANK($O49), """", 4*MIN(10,$O49) + 2*MAX(0,MIN(10,$O49-10)) + 1*MAX(0,$O49-20))","=IF(ISBLANK($O49), """", $O49*30)"
Insulin glargine,SC,10–40 units SC q24h (titrate),q24h,—,—,Start 0.2–0.5 units/kg/day total insulin; split per regimen,0.2–0.5 units/kg/day (titrate),Insulin requirements decrease in renal failure,Requirements may decrease; monitor glucose,,,,,,"=IF(ISBLANK($O50), """", $O50*1.0)","=IF(ISBLANK($O50), """", $O50*1.5)","=IF(ISBLANK($O50), """", $O50*2.0)","=IF(ISBLANK($O50), """", 4*MIN(10,$O50) + 2*MAX(0,MIN(10,$O50-10)) + 1*MAX(0,$O50-20))","=IF(ISBLANK($O50), """", $O50*30)"
Insulin lispro (correctional),SC,1–10+ units SC with meals/HS per sliding scale,AC/HS,—,—,Weight/ISF-based with meals; typical 0.5–1 unit/10–15 g carbs,Similar adolescent dosing with ISF/ICR,Lower requirements with renal failure,Lower requirements with hepatic failure,,,,,,"=IF(ISBLANK($O51), """", $O51*1.0)","=IF(ISBLANK($O51), """", $O51*1.5)","=IF(ISBLANK($O51), """", $O51*2.0)","=IF(ISBLANK($O51), """", 4*MIN(10,$O51) + 2*MAX(0,MIN(10,$O51-10)) + 1*MAX(0,$O51-20))","=IF(ISBLANK($O51), """", $O51*30)"
Dextrose 50%,IV,25 g IV push for hypoglycemia; repeat PRN,PRN,D10W 2–3 mL/kg IV (avoid D50% in neonates),D25W 2 mL/kg IV (or D10W 5 mL/kg),D25W 2 mL/kg or D10W 5 mL/kg,D50W 1 mL/kg (older teens),No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O52), """", $O52*1.0)","=IF(ISBLANK($O52), """", $O52*1.5)","=IF(ISBLANK($O52), """", $O52*2.0)","=IF(ISBLANK($O52), """", 4*MIN(10,$O52) + 2*MAX(0,MIN(10,$O52-10)) + 1*MAX(0,$O52-20))","=IF(ISBLANK($O52), """", $O52*30)"
Glucagon,"IM, IV",1 mg IM/IV for severe hypoglycemia,PRN,—,—,<25 kg: 0.5 mg IM/IV; ≥25 kg: 1 mg,1 mg IM/IV,No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O53), """", $O53*1.0)","=IF(ISBLANK($O53), """", $O53*1.5)","=IF(ISBLANK($O53), """", $O53*2.0)","=IF(ISBLANK($O53), """", 4*MIN(10,$O53) + 2*MAX(0,MIN(10,$O53-10)) + 1*MAX(0,$O53-20))","=IF(ISBLANK($O53), """", $O53*30)"
Levothyroxine,"PO, IV",25–125 mcg PO daily (myxedema coma: 200–400 mcg IV load),Daily,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O54), """", $O54*1.0)","=IF(ISBLANK($O54), """", $O54*1.5)","=IF(ISBLANK($O54), """", $O54*2.0)","=IF(ISBLANK($O54), """", 4*MIN(10,$O54) + 2*MAX(0,MIN(10,$O54-10)) + 1*MAX(0,$O54-20))","=IF(ISBLANK($O54), """", $O54*30)"
Pantoprazole,"IV, PO",40 mg IV/PO q24h (upper GI bleed: 80 mg IV bolus then 8 mg/h),q24h / infusion,—,—,1 mg/kg/day PO (max 40 mg),40 mg q24h,No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O55), """", $O55*1.0)","=IF(ISBLANK($O55), """", $O55*1.5)","=IF(ISBLANK($O55), """", $O55*2.0)","=IF(ISBLANK($O55), """", 4*MIN(10,$O55) + 2*MAX(0,MIN(10,$O55-10)) + 1*MAX(0,$O55-20))","=IF(ISBLANK($O55), """", $O55*30)"
Famotidine,"IV, PO",20 mg PO/IV q12h (CrCl adjust),q12h,—,0.5 mg/kg q12h (max 20 mg/dose),0.5 mg/kg q12h (max 20 mg),20 mg q12h,Adjust if CrCl <50; extend interval,No adjustment,,,,,,"=IF(ISBLANK($O56), """", $O56*1.0)","=IF(ISBLANK($O56), """", $O56*1.5)","=IF(ISBLANK($O56), """", $O56*2.0)","=IF(ISBLANK($O56), """", 4*MIN(10,$O56) + 2*MAX(0,MIN(10,$O56-10)) + 1*MAX(0,$O56-20))","=IF(ISBLANK($O56), """", $O56*30)"
Ondansetron,"IV, PO",4–8 mg IV/PO q8h PRN,q8h PRN,—,0.15 mg/kg IV q8h (max 4 mg/dose),0.15 mg/kg IV/PO q8h (max 8 mg/dose),4–8 mg q8h,No adjustment,Reduce dosing in severe hepatic impairment (max 8 mg/day),,,,,,"=IF(ISBLANK($O57), """", $O57*1.0)","=IF(ISBLANK($O57), """", $O57*1.5)","=IF(ISBLANK($O57), """", $O57*2.0)","=IF(ISBLANK($O57), """", 4*MIN(10,$O57) + 2*MAX(0,MIN(10,$O57-10)) + 1*MAX(0,$O57-20))","=IF(ISBLANK($O57), """", $O57*30)"
Prochlorperazine,"IV, PO",5–10 mg IV/PO q6–8h PRN,q6–8h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O58), """", $O58*1.0)","=IF(ISBLANK($O58), """", $O58*1.5)","=IF(ISBLANK($O58), """", $O58*2.0)","=IF(ISBLANK($O58), """", 4*MIN(10,$O58) + 2*MAX(0,MIN(10,$O58-10)) + 1*MAX(0,$O58-20))","=IF(ISBLANK($O58), """", $O58*30)"
Metoclopramide,"IV, PO",5–10 mg IV/PO q6–8h,q6–8h,—,—,0.1–0.2 mg/kg q6–8h (max 10 mg/dose),Same (monitor EPS),Adjust if CrCl <40,Use caution; reduce dose,,,,,,"=IF(ISBLANK($O59), """", $O59*1.0)","=IF(ISBLANK($O59), """", $O59*1.5)","=IF(ISBLANK($O59), """", $O59*2.0)","=IF(ISBLANK($O59), """", 4*MIN(10,$O59) + 2*MAX(0,MIN(10,$O59-10)) + 1*MAX(0,$O59-20))","=IF(ISBLANK($O59), """", $O59*30)"
Lactulose,PO,"20–30 g PO q1–2h until 2–3 BMs/day, then titrate",q1–2h then TID/QID,—,—,0.7–2 g/kg/day divided to 2–3 soft stools/day,Same goal-based titration,No adjustment,Indicated in hepatic encephalopathy; titrate to 2–3 BMs/day,,,,,,"=IF(ISBLANK($O60), """", $O60*1.0)","=IF(ISBLANK($O60), """", $O60*1.5)","=IF(ISBLANK($O60), """", $O60*2.0)","=IF(ISBLANK($O60), """", 4*MIN(10,$O60) + 2*MAX(0,MIN(10,$O60-10)) + 1*MAX(0,$O60-20))","=IF(ISBLANK($O60), """", $O60*30)"
Rifaximin,PO,550 mg PO q12h,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O61), """", $O61*1.0)","=IF(ISBLANK($O61), """", $O61*1.5)","=IF(ISBLANK($O61), """", $O61*2.0)","=IF(ISBLANK($O61), """", 4*MIN(10,$O61) + 2*MAX(0,MIN(10,$O61-10)) + 1*MAX(0,$O61-20))","=IF(ISBLANK($O61), """", $O61*30)"
Octreotide (bleed),IV,50 mcg IV bolus then 50 mcg/h infusion,Infusion,—,—,1–2 mcg/kg/h infusion (after 1–2 mcg/kg bolus),Similar weight-based dosing,No adjustment,Caution hepatic impairment,,,,,,"=IF(ISBLANK($O62), """", $O62*1.0)","=IF(ISBLANK($O62), """", $O62*1.5)","=IF(ISBLANK($O62), """", $O62*2.0)","=IF(ISBLANK($O62), """", 4*MIN(10,$O62) + 2*MAX(0,MIN(10,$O62-10)) + 1*MAX(0,$O62-20))","=IF(ISBLANK($O62), """", $O62*30)"
Furosemide,"IV, PO",20–80 mg IV/PO q6–12h (higher in CKD),q6–12h,—,0.5–1 mg/kg IV/PO q6–12h,0.5–2 mg/kg IV/PO q6–12h (max 6 mg/kg/day),0.5–1 mg/kg q6–12h (max adult doses),Higher doses in CKD; monitor,Caution hepatic disease (electrolytes),,,,,,"=IF(ISBLANK($O63), """", $O63*1.0)","=IF(ISBLANK($O63), """", $O63*1.5)","=IF(ISBLANK($O63), """", $O63*2.0)","=IF(ISBLANK($O63), """", 4*MIN(10,$O63) + 2*MAX(0,MIN(10,$O63-10)) + 1*MAX(0,$O63-20))","=IF(ISBLANK($O63), """", $O63*30)"
Bumetanide,"IV, PO",0.5–2 mg IV/PO q6–12h,q6–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O64), """", $O64*1.0)","=IF(ISBLANK($O64), """", $O64*1.5)","=IF(ISBLANK($O64), """", $O64*2.0)","=IF(ISBLANK($O64), """", 4*MIN(10,$O64) + 2*MAX(0,MIN(10,$O64-10)) + 1*MAX(0,$O64-20))","=IF(ISBLANK($O64), """", $O64*30)"
Spironolactone,PO,25–100 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O65), """", $O65*1.0)","=IF(ISBLANK($O65), """", $O65*1.5)","=IF(ISBLANK($O65), """", $O65*2.0)","=IF(ISBLANK($O65), """", 4*MIN(10,$O65) + 2*MAX(0,MIN(10,$O65-10)) + 1*MAX(0,$O65-20))","=IF(ISBLANK($O65), """", $O65*30)"
Torsemide,PO,10–40 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O66), """", $O66*1.0)","=IF(ISBLANK($O66), """", $O66*1.5)","=IF(ISBLANK($O66), """", $O66*2.0)","=IF(ISBLANK($O66), """", 4*MIN(10,$O66) + 2*MAX(0,MIN(10,$O66-10)) + 1*MAX(0,$O66-20))","=IF(ISBLANK($O66), """", $O66*30)"
Potassium chloride (oral),PO,20–40 mEq PO q8–12h (max single dose 40 mEq),q8–12h,—,—,1–2 mEq/kg/day divided; max single 20 mEq,Similar; max adult single 40 mEq,Avoid hyperkalemia; reduce/hold in renal failure,No adjustment,,,,,,"=IF(ISBLANK($O67), """", $O67*1.0)","=IF(ISBLANK($O67), """", $O67*1.5)","=IF(ISBLANK($O67), """", $O67*2.0)","=IF(ISBLANK($O67), """", 4*MIN(10,$O67) + 2*MAX(0,MIN(10,$O67-10)) + 1*MAX(0,$O67-20))","=IF(ISBLANK($O67), """", $O67*30)"
Potassium chloride (IV),IV,10–20 mEq/h (central up to 40 mEq/h with monitoring),Per hour,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O68), """", $O68*1.0)","=IF(ISBLANK($O68), """", $O68*1.5)","=IF(ISBLANK($O68), """", $O68*2.0)","=IF(ISBLANK($O68), """", 4*MIN(10,$O68) + 2*MAX(0,MIN(10,$O68-10)) + 1*MAX(0,$O68-20))","=IF(ISBLANK($O68), """", $O68*30)"
Magnesium sulfate,IV,1–2 g IV q1h ×1–4 doses (arrhythmia/low Mg),Per hour,—,—,25–50 mg/kg IV over 1 h (max 2 g),"Same, max adult doses",Caution in renal failure (accumulation),No adjustment,,,,,,"=IF(ISBLANK($O69), """", $O69*1.0)","=IF(ISBLANK($O69), """", $O69*1.5)","=IF(ISBLANK($O69), """", $O69*2.0)","=IF(ISBLANK($O69), """", 4*MIN(10,$O69) + 2*MAX(0,MIN(10,$O69-10)) + 1*MAX(0,$O69-20))","=IF(ISBLANK($O69), """", $O69*30)"
Calcium gluconate,IV,1–2 g IV over 10–20 min,PRN,—,—,50–100 mg/kg elemental Ca IV (≈ 0.5–1 mL/kg of 10%) slow,Same,Caution in renal failure,No adjustment,,,,,,"=IF(ISBLANK($O70), """", $O70*1.0)","=IF(ISBLANK($O70), """", $O70*1.5)","=IF(ISBLANK($O70), """", $O70*2.0)","=IF(ISBLANK($O70), """", 4*MIN(10,$O70) + 2*MAX(0,MIN(10,$O70-10)) + 1*MAX(0,$O70-20))","=IF(ISBLANK($O70), """", $O70*30)"
Sodium bicarbonate,IV,50–150 mEq IV infusion or 50 mEq IV push (code),PRN/infusion,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O71), """", $O71*1.0)","=IF(ISBLANK($O71), """", $O71*1.5)","=IF(ISBLANK($O71), """", $O71*2.0)","=IF(ISBLANK($O71), """", 4*MIN(10,$O71) + 2*MAX(0,MIN(10,$O71-10)) + 1*MAX(0,$O71-20))","=IF(ISBLANK($O71), """", $O71*30)"
Acetaminophen,"PO, IV, PR","650–1,000 mg PO/IV q6–8h (max 3–4 g/day)",q6–8h,—,10–15 mg/kg q6h (max 75 mg/kg/day; do not exceed 4 g/day),10–15 mg/kg q6h,10–15 mg/kg q6h (teen max adult),No adjustment; extend interval if severe renal failure,Reduce max daily dose in hepatic impairment; avoid in acute failure,,,,,,"=IF(ISBLANK($O72), """", $O72*1.0)","=IF(ISBLANK($O72), """", $O72*1.5)","=IF(ISBLANK($O72), """", $O72*2.0)","=IF(ISBLANK($O72), """", 4*MIN(10,$O72) + 2*MAX(0,MIN(10,$O72-10)) + 1*MAX(0,$O72-20))","=IF(ISBLANK($O72), """", $O72*30)"
Ibuprofen,PO,400–800 mg PO q6–8h (max 3.2 g/day),q6–8h,—,—,10 mg/kg q6–8h (max 40 mg/kg/day),10 mg/kg q6–8h (teen max adult),Avoid if severe renal impairment/AKI,Avoid decompensated cirrhosis,,,,,,"=IF(ISBLANK($O73), """", $O73*1.0)","=IF(ISBLANK($O73), """", $O73*1.5)","=IF(ISBLANK($O73), """", $O73*2.0)","=IF(ISBLANK($O73), """", 4*MIN(10,$O73) + 2*MAX(0,MIN(10,$O73-10)) + 1*MAX(0,$O73-20))","=IF(ISBLANK($O73), """", $O73*30)"
Ketorolac,"IV, IM",15–30 mg IV/IM q6h (max 5 days),q6h,—,—,0.5 mg/kg IV q6h (max 15 mg/dose; ≤5 days; ≥2 years),Same limits; avoid if renal risk,Contraindicated/avoid in renal failure,Use caution; avoid advanced hepatic disease/bleeding risk,,,,,,"=IF(ISBLANK($O74), """", $O74*1.0)","=IF(ISBLANK($O74), """", $O74*1.5)","=IF(ISBLANK($O74), """", $O74*2.0)","=IF(ISBLANK($O74), """", 4*MIN(10,$O74) + 2*MAX(0,MIN(10,$O74-10)) + 1*MAX(0,$O74-20))","=IF(ISBLANK($O74), """", $O74*30)"
Oxycodone,PO,5–10 mg PO q4–6h PRN (opioid‑naïve),q4–6h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O75), """", $O75*1.0)","=IF(ISBLANK($O75), """", $O75*1.5)","=IF(ISBLANK($O75), """", $O75*2.0)","=IF(ISBLANK($O75), """", 4*MIN(10,$O75) + 2*MAX(0,MIN(10,$O75-10)) + 1*MAX(0,$O75-20))","=IF(ISBLANK($O75), """", $O75*30)"
Hydromorphone (IV),IV,0.2–1 mg IV q2–4h PRN,q2–4h PRN,—,—,0.01–0.02 mg/kg IV q3–4h PRN,Same,Reduce dose in renal failure,Reduce dose in hepatic failure,,,,,,"=IF(ISBLANK($O76), """", $O76*1.0)","=IF(ISBLANK($O76), """", $O76*1.5)","=IF(ISBLANK($O76), """", $O76*2.0)","=IF(ISBLANK($O76), """", 4*MIN(10,$O76) + 2*MAX(0,MIN(10,$O76-10)) + 1*MAX(0,$O76-20))","=IF(ISBLANK($O76), """", $O76*30)"
Morphine (IV),IV,2–4 mg IV q2–4h PRN,q2–4h PRN,—,—,0.05–0.1 mg/kg IV q2–4h PRN,Same; titrate,Reduce dose in renal failure (active metabolites),Reduce dose in hepatic impairment,,,,,,"=IF(ISBLANK($O77), """", $O77*1.0)","=IF(ISBLANK($O77), """", $O77*1.5)","=IF(ISBLANK($O77), """", $O77*2.0)","=IF(ISBLANK($O77), """", 4*MIN(10,$O77) + 2*MAX(0,MIN(10,$O77-10)) + 1*MAX(0,$O77-20))","=IF(ISBLANK($O77), """", $O77*30)"
Fentanyl (IV),IV,25–100 mcg IV q30–60min PRN or infusion 25–200 mcg/h,PRN / infusion,—,—,0.5–2 mcg/kg IV q30–60min PRN; infusion 0.5–3 mcg/kg/h,Same,No adjustment; preferred in renal failure,Reduce dose in severe hepatic impairment,,,,,,"=IF(ISBLANK($O78), """", $O78*1.0)","=IF(ISBLANK($O78), """", $O78*1.5)","=IF(ISBLANK($O78), """", $O78*2.0)","=IF(ISBLANK($O78), """", 4*MIN(10,$O78) + 2*MAX(0,MIN(10,$O78-10)) + 1*MAX(0,$O78-20))","=IF(ISBLANK($O78), """", $O78*30)"
Propofol,IV,5–80 mcg/kg/min titrated (induction 1–2.5 mg/kg),Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O79), """", $O79*1.0)","=IF(ISBLANK($O79), """", $O79*1.5)","=IF(ISBLANK($O79), """", $O79*2.0)","=IF(ISBLANK($O79), """", 4*MIN(10,$O79) + 2*MAX(0,MIN(10,$O79-10)) + 1*MAX(0,$O79-20))","=IF(ISBLANK($O79), """", $O79*30)"
Dexmedetomidine,IV,0.2–1.5 mcg/kg/h titrated,Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O80), """", $O80*1.0)","=IF(ISBLANK($O80), """", $O80*1.5)","=IF(ISBLANK($O80), """", $O80*2.0)","=IF(ISBLANK($O80), """", 4*MIN(10,$O80) + 2*MAX(0,MIN(10,$O80-10)) + 1*MAX(0,$O80-20))","=IF(ISBLANK($O80), """", $O80*30)"
Lorazepam,"IV, PO",0.5–2 mg IV/PO q4–6h PRN (ETOH withdrawal protocols vary),q4–6h PRN,—,—,0.05–0.1 mg/kg IV/PO q4–6h PRN,Same,No adjustment (propylene glycol load IV—monitor),Use caution; reduce dose,,,,,,"=IF(ISBLANK($O81), """", $O81*1.0)","=IF(ISBLANK($O81), """", $O81*1.5)","=IF(ISBLANK($O81), """", $O81*2.0)","=IF(ISBLANK($O81), """", 4*MIN(10,$O81) + 2*MAX(0,MIN(10,$O81-10)) + 1*MAX(0,$O81-20))","=IF(ISBLANK($O81), """", $O81*30)"
Diazepam,"IV, PO",5–10 mg IV/PO q6–8h PRN,q6–8h PRN,—,—,0.2–0.5 mg/kg PR for seizures; IV 0.2 mg/kg slow push,Similar,No adjustment,Avoid severe hepatic impairment,,,,,,"=IF(ISBLANK($O82), """", $O82*1.0)","=IF(ISBLANK($O82), """", $O82*1.5)","=IF(ISBLANK($O82), """", $O82*2.0)","=IF(ISBLANK($O82), """", 4*MIN(10,$O82) + 2*MAX(0,MIN(10,$O82-10)) + 1*MAX(0,$O82-20))","=IF(ISBLANK($O82), """", $O82*30)"
Haloperidol,"IV, IM, PO",1–5 mg IV/IM/PO q4–6h PRN,q4–6h PRN,—,—,0.02–0.05 mg/kg/dose q6–8h PRN (max per institution),0.5–2 mg q6–8h PRN (teen),No adjustment,Reduce dose in hepatic impairment,,,,,,"=IF(ISBLANK($O83), """", $O83*1.0)","=IF(ISBLANK($O83), """", $O83*1.5)","=IF(ISBLANK($O83), """", $O83*2.0)","=IF(ISBLANK($O83), """", 4*MIN(10,$O83) + 2*MAX(0,MIN(10,$O83-10)) + 1*MAX(0,$O83-20))","=IF(ISBLANK($O83), """", $O83*30)"
Quetiapine,PO,25–100 mg PO q12h (titrate),q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O84), """", $O84*1.0)","=IF(ISBLANK($O84), """", $O84*1.5)","=IF(ISBLANK($O84), """", $O84*2.0)","=IF(ISBLANK($O84), """", 4*MIN(10,$O84) + 2*MAX(0,MIN(10,$O84-10)) + 1*MAX(0,$O84-20))","=IF(ISBLANK($O84), """", $O84*30)"
Olanzapine,"PO, IM",2.5–10 mg PO/IM q12–24h,q12–24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O85), """", $O85*1.0)","=IF(ISBLANK($O85), """", $O85*1.5)","=IF(ISBLANK($O85), """", $O85*2.0)","=IF(ISBLANK($O85), """", 4*MIN(10,$O85) + 2*MAX(0,MIN(10,$O85-10)) + 1*MAX(0,$O85-20))","=IF(ISBLANK($O85), """", $O85*30)"
Levetiracetam,"IV, PO","500–1,500 mg IV/PO q12h",q12h,—,10–20 mg/kg q12h (titrate),10–30 mg/kg q12h (max 1.5 g q12h),Adult-like max 1.5 g q12h,Adjust by CrCl,No adjustment,,,,,,"=IF(ISBLANK($O86), """", $O86*1.0)","=IF(ISBLANK($O86), """", $O86*1.5)","=IF(ISBLANK($O86), """", $O86*2.0)","=IF(ISBLANK($O86), """", 4*MIN(10,$O86) + 2*MAX(0,MIN(10,$O86-10)) + 1*MAX(0,$O86-20))","=IF(ISBLANK($O86), """", $O86*30)"
Valproate (IV),"IV, PO",15–45 mg/kg/day divided q8–12h,q8–12h,—,—,10–15 mg/kg/day start; increase to 60 mg/kg/day divided,Same,No adjustment; monitor,Contraindicated in significant hepatic disease,,,,,,"=IF(ISBLANK($O87), """", $O87*1.0)","=IF(ISBLANK($O87), """", $O87*1.5)","=IF(ISBLANK($O87), """", $O87*2.0)","=IF(ISBLANK($O87), """", 4*MIN(10,$O87) + 2*MAX(0,MIN(10,$O87-10)) + 1*MAX(0,$O87-20))","=IF(ISBLANK($O87), """", $O87*30)"
Lacosamide,"IV, PO",100–200 mg IV/PO q12h,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O88), """", $O88*1.0)","=IF(ISBLANK($O88), """", $O88*1.5)","=IF(ISBLANK($O88), """", $O88*2.0)","=IF(ISBLANK($O88), """", 4*MIN(10,$O88) + 2*MAX(0,MIN(10,$O88-10)) + 1*MAX(0,$O88-20))","=IF(ISBLANK($O88), """", $O88*30)"
Phenytoin/fosphenytoin,"IV, PO",Load 15–20 mg/kg IV; maintain 4–6 mg/kg/day divided,q8–12h,—,—,Load 15–20 mg/kg; maintenance 5–8 mg/kg/day divided,Same,No adjustment; monitor levels (albumin/renal correction),Reduce dose; monitor in hepatic impairment (protein binding),,,,,,"=IF(ISBLANK($O89), """", $O89*1.0)","=IF(ISBLANK($O89), """", $O89*1.5)","=IF(ISBLANK($O89), """", $O89*2.0)","=IF(ISBLANK($O89), """", 4*MIN(10,$O89) + 2*MAX(0,MIN(10,$O89-10)) + 1*MAX(0,$O89-20))","=IF(ISBLANK($O89), """", $O89*30)"
Mannitol,IV,0.25–1 g/kg IV q6–8h PRN ICP,q6–8h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O90), """", $O90*1.0)","=IF(ISBLANK($O90), """", $O90*1.5)","=IF(ISBLANK($O90), """", $O90*2.0)","=IF(ISBLANK($O90), """", 4*MIN(10,$O90) + 2*MAX(0,MIN(10,$O90-10)) + 1*MAX(0,$O90-20))","=IF(ISBLANK($O90), """", $O90*30)"
Nicardipine infusion,IV,2.5–15 mg/h titrated for BP,Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O91), """", $O91*1.0)","=IF(ISBLANK($O91), """", $O91*1.5)","=IF(ISBLANK($O91), """", $O91*2.0)","=IF(ISBLANK($O91), """", 4*MIN(10,$O91) + 2*MAX(0,MIN(10,$O91-10)) + 1*MAX(0,$O91-20))","=IF(ISBLANK($O91), """", $O91*30)"
Cefotaxime,IV,1–2 g IV q6–8h,q6–8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O92), """", $O92*1.0)","=IF(ISBLANK($O92), """", $O92*1.5)","=IF(ISBLANK($O92), """", $O92*2.0)","=IF(ISBLANK($O92), """", 4*MIN(10,$O92) + 2*MAX(0,MIN(10,$O92-10)) + 1*MAX(0,$O92-20))","=IF(ISBLANK($O92), """", $O92*30)"
Gentamicin,IV,5–7 mg/kg IV q24h (extended‑interval),q24h,Neonate 4–5 mg/kg q24–48h (GA/PMa dependent),7.5 mg/kg/day divided q8h or extended-interval 5–7 mg/kg q24h,"5–7 mg/kg IV q24h (EI dosing, levels)",Same,Adjust by levels and CrCl; post-HD dosing,No adjustment,,,,,,"=IF(ISBLANK($O93), """", $O93*1.0)","=IF(ISBLANK($O93), """", $O93*1.5)","=IF(ISBLANK($O93), """", $O93*2.0)","=IF(ISBLANK($O93), """", 4*MIN(10,$O93) + 2*MAX(0,MIN(10,$O93-10)) + 1*MAX(0,$O93-20))","=IF(ISBLANK($O93), """", $O93*30)"
Tobramycin,IV,5–7 mg/kg IV q24h,q24h,—,—,5–7 mg/kg IV q24h (levels),Same,Adjust by levels/CrCl,No adjustment,,,,,,"=IF(ISBLANK($O94), """", $O94*1.0)","=IF(ISBLANK($O94), """", $O94*1.5)","=IF(ISBLANK($O94), """", $O94*2.0)","=IF(ISBLANK($O94), """", 4*MIN(10,$O94) + 2*MAX(0,MIN(10,$O94-10)) + 1*MAX(0,$O94-20))","=IF(ISBLANK($O94), """", $O94*30)"
Colistin (colistimethate),IV,2.5–5 mg/kg/day colistin base divided (specialist dosing),q8–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O95), """", $O95*1.0)","=IF(ISBLANK($O95), """", $O95*1.5)","=IF(ISBLANK($O95), """", $O95*2.0)","=IF(ISBLANK($O95), """", 4*MIN(10,$O95) + 2*MAX(0,MIN(10,$O95-10)) + 1*MAX(0,$O95-20))","=IF(ISBLANK($O95), """", $O95*30)"
Filgrastim,SC,5 mcg/kg SC daily,Daily,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O96), """", $O96*1.0)","=IF(ISBLANK($O96), """", $O96*1.5)","=IF(ISBLANK($O96), """", $O96*2.0)","=IF(ISBLANK($O96), """", 4*MIN(10,$O96) + 2*MAX(0,MIN(10,$O96-10)) + 1*MAX(0,$O96-20))","=IF(ISBLANK($O96), """", $O96*30)"
Allopurinol,PO,100–300 mg PO q24h (TLS up to 800 mg/day),q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O97), """", $O97*1.0)","=IF(ISBLANK($O97), """", $O97*1.5)","=IF(ISBLANK($O97), """", $O97*2.0)","=IF(ISBLANK($O97), """", 4*MIN(10,$O97) + 2*MAX(0,MIN(10,$O97-10)) + 1*MAX(0,$O97-20))","=IF(ISBLANK($O97), """", $O97*30)"
Rasburicase,IV,0.1–0.2 mg/kg IV once daily (1–5 doses),Daily,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O98), """", $O98*1.0)","=IF(ISBLANK($O98), """", $O98*1.5)","=IF(ISBLANK($O98), """", $O98*2.0)","=IF(ISBLANK($O98), """", 4*MIN(10,$O98) + 2*MAX(0,MIN(10,$O98-10)) + 1*MAX(0,$O98-20))","=IF(ISBLANK($O98), """", $O98*30)"
Dexamethasone,"IV, PO",4–10 mg IV/PO q6–12h (varies by indication),q6–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O99), """", $O99*1.0)","=IF(ISBLANK($O99), """", $O99*1.5)","=IF(ISBLANK($O99), """", $O99*2.0)","=IF(ISBLANK($O99), """", 4*MIN(10,$O99) + 2*MAX(0,MIN(10,$O99-10)) + 1*MAX(0,$O99-20))","=IF(ISBLANK($O99), """", $O99*30)"
Normal saline (0.9% NaCl),IV,"Bolus 500–1,000 mL; maintenance 75–150 mL/h",Continuous/bolus,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,"Bolus, Maintenance, Carrier","Choose: 10, 25, 50, 75, 100, 125, 150, 175, 200 mL/h",Wt-based: 30 mL/kg/day (≈1–2 mL/kg/h) or 1–1.5 mL/kg/h ICU target,4-2-1 rule: 4 mL/kg/h (first 10 kg) + 2 mL/kg/h (next 10 kg) + 1 mL/kg/h (each kg >20),,"=IF(ISBLANK($O100), """", $O100*1.0)","=IF(ISBLANK($O100), """", $O100*1.5)","=IF(ISBLANK($O100), """", $O100*2.0)","=IF(ISBLANK($O100), """", 4*MIN(10,$O100) + 2*MAX(0,MIN(10,$O100-10)) + 1*MAX(0,$O100-20))","=IF(ISBLANK($O100), """", $O100*30)"
Lactated Ringer’s,IV,"Bolus 500–1,000 mL; maintenance per need",Continuous/bolus,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,"Bolus, Maintenance, Carrier","Choose: 10, 25, 50, 75, 100, 125, 150, 175, 200 mL/h",Wt-based: 30 mL/kg/day (≈1–2 mL/kg/h) or 1–1.5 mL/kg/h ICU target,4-2-1 rule: 4 mL/kg/h (first 10 kg) + 2 mL/kg/h (next 10 kg) + 1 mL/kg/h (each kg >20),,"=IF(ISBLANK($O101), """", $O101*1.0)","=IF(ISBLANK($O101), """", $O101*1.5)","=IF(ISBLANK($O101), """", $O101*2.0)","=IF(ISBLANK($O101), """", 4*MIN(10,$O101) + 2*MAX(0,MIN(10,$O101-10)) + 1*MAX(0,$O101-20))","=IF(ISBLANK($O101), """", $O101*30)"
D5W,IV,Maintenance 50–125 mL/h,Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,"Bolus, Maintenance, Carrier","Choose: 10, 25, 50, 75, 100, 125, 150, 175, 200 mL/h",Wt-based: 30 mL/kg/day (≈1–2 mL/kg/h) or 1–1.5 mL/kg/h ICU target,4-2-1 rule: 4 mL/kg/h (first 10 kg) + 2 mL/kg/h (next 10 kg) + 1 mL/kg/h (each kg >20),,"=IF(ISBLANK($O102), """", $O102*1.0)","=IF(ISBLANK($O102), """", $O102*1.5)","=IF(ISBLANK($O102), """", $O102*2.0)","=IF(ISBLANK($O102), """", 4*MIN(10,$O102) + 2*MAX(0,MIN(10,$O102-10)) + 1*MAX(0,$O102-20))","=IF(ISBLANK($O102), """", $O102*30)"
D10W (hypoglycemia),IV,100–250 mL bolus; infusion per protocol,PRN/infusion,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,"Bolus, Maintenance, Carrier","Choose: 10, 25, 50, 75, 100, 125, 150, 175, 200 mL/h",Wt-based: 30 mL/kg/day (≈1–2 mL/kg/h) or 1–1.5 mL/kg/h ICU target,4-2-1 rule: 4 mL/kg/h (first 10 kg) + 2 mL/kg/h (next 10 kg) + 1 mL/kg/h (each kg >20),,"=IF(ISBLANK($O103), """", $O103*1.0)","=IF(ISBLANK($O103), """", $O103*1.5)","=IF(ISBLANK($O103), """", $O103*2.0)","=IF(ISBLANK($O103), """", 4*MIN(10,$O103) + 2*MAX(0,MIN(10,$O103-10)) + 1*MAX(0,$O103-20))","=IF(ISBLANK($O103), """", $O103*30)"
Tamsulosin,PO,0.4 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O104), """", $O104*1.0)","=IF(ISBLANK($O104), """", $O104*1.5)","=IF(ISBLANK($O104), """", $O104*2.0)","=IF(ISBLANK($O104), """", 4*MIN(10,$O104) + 2*MAX(0,MIN(10,$O104-10)) + 1*MAX(0,$O104-20))","=IF(ISBLANK($O104), """", $O104*30)"
Oxybutynin,PO,5 mg PO q8–12h,q8–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O105), """", $O105*1.0)","=IF(ISBLANK($O105), """", $O105*1.5)","=IF(ISBLANK($O105), """", $O105*2.0)","=IF(ISBLANK($O105), """", 4*MIN(10,$O105) + 2*MAX(0,MIN(10,$O105-10)) + 1*MAX(0,$O105-20))","=IF(ISBLANK($O105), """", $O105*30)"
Phenazopyridine,PO,100–200 mg PO q8h after meals,q8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O106), """", $O106*1.0)","=IF(ISBLANK($O106), """", $O106*1.5)","=IF(ISBLANK($O106), """", $O106*2.0)","=IF(ISBLANK($O106), """", 4*MIN(10,$O106) + 2*MAX(0,MIN(10,$O106-10)) + 1*MAX(0,$O106-20))","=IF(ISBLANK($O106), """", $O106*30)"
Vancomycin (oral),PO,125–500 mg PO q6h (severity‑based),q6h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O107), """", $O107*1.0)","=IF(ISBLANK($O107), """", $O107*1.5)","=IF(ISBLANK($O107), """", $O107*2.0)","=IF(ISBLANK($O107), """", 4*MIN(10,$O107) + 2*MAX(0,MIN(10,$O107-10)) + 1*MAX(0,$O107-20))","=IF(ISBLANK($O107), """", $O107*30)"
Fidaxomicin,PO,200 mg PO q12h ×10 days,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O108), """", $O108*1.0)","=IF(ISBLANK($O108), """", $O108*1.5)","=IF(ISBLANK($O108), """", $O108*2.0)","=IF(ISBLANK($O108), """", 4*MIN(10,$O108) + 2*MAX(0,MIN(10,$O108-10)) + 1*MAX(0,$O108-20))","=IF(ISBLANK($O108), """", $O108*30)"
Bezlotoxumab,IV,10 mg/kg IV once,Once,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O109), """", $O109*1.0)","=IF(ISBLANK($O109), """", $O109*1.5)","=IF(ISBLANK($O109), """", $O109*2.0)","=IF(ISBLANK($O109), """", 4*MIN(10,$O109) + 2*MAX(0,MIN(10,$O109-10)) + 1*MAX(0,$O109-20))","=IF(ISBLANK($O109), """", $O109*30)"
Fondaparinux (prophylaxis),SC,2.5 mg SC q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O110), """", $O110*1.0)","=IF(ISBLANK($O110), """", $O110*1.5)","=IF(ISBLANK($O110), """", $O110*2.0)","=IF(ISBLANK($O110), """", 4*MIN(10,$O110) + 2*MAX(0,MIN(10,$O110-10)) + 1*MAX(0,$O110-20))","=IF(ISBLANK($O110), """", $O110*30)"
Gabapentin,PO,100–300 mg PO q8h (titrate),q8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O111), """", $O111*1.0)","=IF(ISBLANK($O111), """", $O111*1.5)","=IF(ISBLANK($O111), """", $O111*2.0)","=IF(ISBLANK($O111), """", 4*MIN(10,$O111) + 2*MAX(0,MIN(10,$O111-10)) + 1*MAX(0,$O111-20))","=IF(ISBLANK($O111), """", $O111*30)"
Pregabalin,PO,50–150 mg PO q12h,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O112), """", $O112*1.0)","=IF(ISBLANK($O112), """", $O112*1.5)","=IF(ISBLANK($O112), """", $O112*2.0)","=IF(ISBLANK($O112), """", 4*MIN(10,$O112) + 2*MAX(0,MIN(10,$O112-10)) + 1*MAX(0,$O112-20))","=IF(ISBLANK($O112), """", $O112*30)"
Methocarbamol,"PO, IV","500–1,000 mg PO/IV q6–8h",q6–8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O113), """", $O113*1.0)","=IF(ISBLANK($O113), """", $O113*1.5)","=IF(ISBLANK($O113), """", $O113*2.0)","=IF(ISBLANK($O113), """", 4*MIN(10,$O113) + 2*MAX(0,MIN(10,$O113-10)) + 1*MAX(0,$O113-20))","=IF(ISBLANK($O113), """", $O113*30)"
Melatonin,PO,3–10 mg PO HS,HS,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O114), """", $O114*1.0)","=IF(ISBLANK($O114), """", $O114*1.5)","=IF(ISBLANK($O114), """", $O114*2.0)","=IF(ISBLANK($O114), """", 4*MIN(10,$O114) + 2*MAX(0,MIN(10,$O114-10)) + 1*MAX(0,$O114-20))","=IF(ISBLANK($O114), """", $O114*30)"
Trazodone,PO,25–100 mg PO HS PRN,HS PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O115), """", $O115*1.0)","=IF(ISBLANK($O115), """", $O115*1.5)","=IF(ISBLANK($O115), """", $O115*2.0)","=IF(ISBLANK($O115), """", 4*MIN(10,$O115) + 2*MAX(0,MIN(10,$O115-10)) + 1*MAX(0,$O115-20))","=IF(ISBLANK($O115), """", $O115*30)"
Valproate (PO),PO,250–500 mg PO q8–12h (behavioral off‑label varies),q8–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O116), """", $O116*1.0)","=IF(ISBLANK($O116), """", $O116*1.5)","=IF(ISBLANK($O116), """", $O116*2.0)","=IF(ISBLANK($O116), """", 4*MIN(10,$O116) + 2*MAX(0,MIN(10,$O116-10)) + 1*MAX(0,$O116-20))","=IF(ISBLANK($O116), """", $O116*30)"
Cefuroxime,IV,1.5 g IV q8h,q8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O117), """", $O117*1.0)","=IF(ISBLANK($O117), """", $O117*1.5)","=IF(ISBLANK($O117), """", $O117*2.0)","=IF(ISBLANK($O117), """", 4*MIN(10,$O117) + 2*MAX(0,MIN(10,$O117-10)) + 1*MAX(0,$O117-20))","=IF(ISBLANK($O117), """", $O117*30)"
Cefoxitin,IV,1–2 g IV q6–8h,q6–8h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O118), """", $O118*1.0)","=IF(ISBLANK($O118), """", $O118*1.5)","=IF(ISBLANK($O118), """", $O118*2.0)","=IF(ISBLANK($O118), """", 4*MIN(10,$O118) + 2*MAX(0,MIN(10,$O118-10)) + 1*MAX(0,$O118-20))","=IF(ISBLANK($O118), """", $O118*30)"
Vasopressin,IV,0.01–0.04 units/min,Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O119), """", $O119*1.0)","=IF(ISBLANK($O119), """", $O119*1.5)","=IF(ISBLANK($O119), """", $O119*2.0)","=IF(ISBLANK($O119), """", 4*MIN(10,$O119) + 2*MAX(0,MIN(10,$O119-10)) + 1*MAX(0,$O119-20))","=IF(ISBLANK($O119), """", $O119*30)"
Methylene blue,IV,1–2 mg/kg IV over 20–60 min (refractory vasoplegia),Once +/- repeat,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O120), """", $O120*1.0)","=IF(ISBLANK($O120), """", $O120*1.5)","=IF(ISBLANK($O120), """", $O120*2.0)","=IF(ISBLANK($O120), """", 4*MIN(10,$O120) + 2*MAX(0,MIN(10,$O120-10)) + 1*MAX(0,$O120-20))","=IF(ISBLANK($O120), """", $O120*30)"
Hydrocortisone (septic shock),IV,50 mg IV q6h,q6h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O121), """", $O121*1.0)","=IF(ISBLANK($O121), """", $O121*1.5)","=IF(ISBLANK($O121), """", $O121*2.0)","=IF(ISBLANK($O121), """", 4*MIN(10,$O121) + 2*MAX(0,MIN(10,$O121-10)) + 1*MAX(0,$O121-20))","=IF(ISBLANK($O121), """", $O121*30)"
Diphenhydramine,"IV, PO",25–50 mg IV/PO q6h PRN,q6h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O122), """", $O122*1.0)","=IF(ISBLANK($O122), """", $O122*1.5)","=IF(ISBLANK($O122), """", $O122*2.0)","=IF(ISBLANK($O122), """", 4*MIN(10,$O122) + 2*MAX(0,MIN(10,$O122-10)) + 1*MAX(0,$O122-20))","=IF(ISBLANK($O122), """", $O122*30)"
Cetirizine,PO,10 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O123), """", $O123*1.0)","=IF(ISBLANK($O123), """", $O123*1.5)","=IF(ISBLANK($O123), """", $O123*2.0)","=IF(ISBLANK($O123), """", 4*MIN(10,$O123) + 2*MAX(0,MIN(10,$O123-10)) + 1*MAX(0,$O123-20))","=IF(ISBLANK($O123), """", $O123*30)"
Montelukast,PO,10 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O124), """", $O124*1.0)","=IF(ISBLANK($O124), """", $O124*1.5)","=IF(ISBLANK($O124), """", $O124*2.0)","=IF(ISBLANK($O124), """", 4*MIN(10,$O124) + 2*MAX(0,MIN(10,$O124-10)) + 1*MAX(0,$O124-20))","=IF(ISBLANK($O124), """", $O124*30)"
Budesonide (neb),INH,0.5–1 mg neb q12h,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O125), """", $O125*1.0)","=IF(ISBLANK($O125), """", $O125*1.5)","=IF(ISBLANK($O125), """", $O125*2.0)","=IF(ISBLANK($O125), """", 4*MIN(10,$O125) + 2*MAX(0,MIN(10,$O125-10)) + 1*MAX(0,$O125-20))","=IF(ISBLANK($O125), """", $O125*30)"
Formoterol (neb),INH,20 mcg neb q12h,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O126), """", $O126*1.0)","=IF(ISBLANK($O126), """", $O126*1.5)","=IF(ISBLANK($O126), """", $O126*2.0)","=IF(ISBLANK($O126), """", 4*MIN(10,$O126) + 2*MAX(0,MIN(10,$O126-10)) + 1*MAX(0,$O126-20))","=IF(ISBLANK($O126), """", $O126*30)"
Regular insulin (IV),IV,0.05–0.1 units/kg/h infusion (DKA),Continuous,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O127), """", $O127*1.0)","=IF(ISBLANK($O127), """", $O127*1.5)","=IF(ISBLANK($O127), """", $O127*2.0)","=IF(ISBLANK($O127), """", 4*MIN(10,$O127) + 2*MAX(0,MIN(10,$O127-10)) + 1*MAX(0,$O127-20))","=IF(ISBLANK($O127), """", $O127*30)"
Phosphate (KPhos/NaPhos),IV,15–30 mmol IV over 2–6 h,Per dose,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O128), """", $O128*1.0)","=IF(ISBLANK($O128), """", $O128*1.5)","=IF(ISBLANK($O128), """", $O128*2.0)","=IF(ISBLANK($O128), """", 4*MIN(10,$O128) + 2*MAX(0,MIN(10,$O128-10)) + 1*MAX(0,$O128-20))","=IF(ISBLANK($O128), """", $O128*30)"
Voriconazole,"IV, PO",4 mg/kg IV/PO q12h after 6 mg/kg ×2 load,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O129), """", $O129*1.0)","=IF(ISBLANK($O129), """", $O129*1.5)","=IF(ISBLANK($O129), """", $O129*2.0)","=IF(ISBLANK($O129), """", 4*MIN(10,$O129) + 2*MAX(0,MIN(10,$O129-10)) + 1*MAX(0,$O129-20))","=IF(ISBLANK($O129), """", $O129*30)"
Amphotericin B (liposomal),IV,3–5 mg/kg IV q24h,q24h,—,3–5 mg/kg q24h,3–5 mg/kg q24h,Same,No adjustment (nephrotoxic—monitor),No adjustment,,,,,,"=IF(ISBLANK($O130), """", $O130*1.0)","=IF(ISBLANK($O130), """", $O130*1.5)","=IF(ISBLANK($O130), """", $O130*2.0)","=IF(ISBLANK($O130), """", 4*MIN(10,$O130) + 2*MAX(0,MIN(10,$O130-10)) + 1*MAX(0,$O130-20))","=IF(ISBLANK($O130), """", $O130*30)"
Isoniazid,PO,300 mg PO q24h,q24h,—,—,10–15 mg/kg q24h (max 300 mg) + pyridoxine,Same,No adjustment,Use caution/monitor LFTs; avoid severe hepatic disease,,,,,,"=IF(ISBLANK($O131), """", $O131*1.0)","=IF(ISBLANK($O131), """", $O131*1.5)","=IF(ISBLANK($O131), """", $O131*2.0)","=IF(ISBLANK($O131), """", 4*MIN(10,$O131) + 2*MAX(0,MIN(10,$O131-10)) + 1*MAX(0,$O131-20))","=IF(ISBLANK($O131), """", $O131*30)"
Rifampin,PO,600 mg PO q24h,q24h,—,—,10–20 mg/kg q24h (max 600 mg),Same,No adjustment,Avoid severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O132), """", $O132*1.0)","=IF(ISBLANK($O132), """", $O132*1.5)","=IF(ISBLANK($O132), """", $O132*2.0)","=IF(ISBLANK($O132), """", 4*MIN(10,$O132) + 2*MAX(0,MIN(10,$O132-10)) + 1*MAX(0,$O132-20))","=IF(ISBLANK($O132), """", $O132*30)"
Pyrazinamide,PO,15–30 mg/kg PO q24h,q24h,—,—,20–40 mg/kg q24h (max 2 g),Same,Adjust in renal failure (TIW dosing possible),Avoid severe hepatic disease,,,,,,"=IF(ISBLANK($O133), """", $O133*1.0)","=IF(ISBLANK($O133), """", $O133*1.5)","=IF(ISBLANK($O133), """", $O133*2.0)","=IF(ISBLANK($O133), """", 4*MIN(10,$O133) + 2*MAX(0,MIN(10,$O133-10)) + 1*MAX(0,$O133-20))","=IF(ISBLANK($O133), """", $O133*30)"
Ethambutol,PO,15–25 mg/kg PO q24h,q24h,—,—,15–25 mg/kg q24h,Same,Adjust if CrCl reduced,No adjustment,,,,,,"=IF(ISBLANK($O134), """", $O134*1.0)","=IF(ISBLANK($O134), """", $O134*1.5)","=IF(ISBLANK($O134), """", $O134*2.0)","=IF(ISBLANK($O134), """", 4*MIN(10,$O134) + 2*MAX(0,MIN(10,$O134-10)) + 1*MAX(0,$O134-20))","=IF(ISBLANK($O134), """", $O134*30)"
Thiamine,"IV, PO",100 mg IV/PO q24h (Wernicke: 200–500 mg IV TID),q24h (or TID),—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O135), """", $O135*1.0)","=IF(ISBLANK($O135), """", $O135*1.5)","=IF(ISBLANK($O135), """", $O135*2.0)","=IF(ISBLANK($O135), """", 4*MIN(10,$O135) + 2*MAX(0,MIN(10,$O135-10)) + 1*MAX(0,$O135-20))","=IF(ISBLANK($O135), """", $O135*30)"
Folic acid,PO,1 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O136), """", $O136*1.0)","=IF(ISBLANK($O136), """", $O136*1.5)","=IF(ISBLANK($O136), """", $O136*2.0)","=IF(ISBLANK($O136), """", 4*MIN(10,$O136) + 2*MAX(0,MIN(10,$O136-10)) + 1*MAX(0,$O136-20))","=IF(ISBLANK($O136), """", $O136*30)"
Cyanocobalamin,"IM, PO","1,000 mcg IM monthly (daily ×1wk for deficiency)",Monthly/daily (loading),—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O137), """", $O137*1.0)","=IF(ISBLANK($O137), """", $O137*1.5)","=IF(ISBLANK($O137), """", $O137*2.0)","=IF(ISBLANK($O137), """", 4*MIN(10,$O137) + 2*MAX(0,MIN(10,$O137-10)) + 1*MAX(0,$O137-20))","=IF(ISBLANK($O137), """", $O137*30)"
Ferrous sulfate,PO,325 mg PO q24–48h (elemental Fe 65 mg),q24–48h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O138), """", $O138*1.0)","=IF(ISBLANK($O138), """", $O138*1.5)","=IF(ISBLANK($O138), """", $O138*2.0)","=IF(ISBLANK($O138), """", 4*MIN(10,$O138) + 2*MAX(0,MIN(10,$O138-10)) + 1*MAX(0,$O138-20))","=IF(ISBLANK($O138), """", $O138*30)"
Naloxone,"IV, IN, IM",0.04–2 mg IV/IN/IM; repeat PRN; infusion 0.4–4 mg/h,PRN / infusion,—,—,0.1 mg/kg IV/IM/IN (max 2 mg); repeat PRN,Same; infusion 0.002–0.16 mg/kg/h if needed,No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O139), """", $O139*1.0)","=IF(ISBLANK($O139), """", $O139*1.5)","=IF(ISBLANK($O139), """", $O139*2.0)","=IF(ISBLANK($O139), """", 4*MIN(10,$O139) + 2*MAX(0,MIN(10,$O139-10)) + 1*MAX(0,$O139-20))","=IF(ISBLANK($O139), """", $O139*30)"
Flumazenil,IV,0.2 mg IV over 15 sec; repeat to 1 mg,PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O140), """", $O140*1.0)","=IF(ISBLANK($O140), """", $O140*1.5)","=IF(ISBLANK($O140), """", $O140*2.0)","=IF(ISBLANK($O140), """", 4*MIN(10,$O140) + 2*MAX(0,MIN(10,$O140-10)) + 1*MAX(0,$O140-20))","=IF(ISBLANK($O140), """", $O140*30)"
Chlorhexidine oral rinse,PO (rinse),15 mL swish q12h,q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O141), """", $O141*1.0)","=IF(ISBLANK($O141), """", $O141*1.5)","=IF(ISBLANK($O141), """", $O141*2.0)","=IF(ISBLANK($O141), """", 4*MIN(10,$O141) + 2*MAX(0,MIN(10,$O141-10)) + 1*MAX(0,$O141-20))","=IF(ISBLANK($O141), """", $O141*30)"
Heparin (SC prophylaxis),SC,"5,000 units SC q8–12h",q8–12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O142), """", $O142*1.0)","=IF(ISBLANK($O142), """", $O142*1.5)","=IF(ISBLANK($O142), """", $O142*2.0)","=IF(ISBLANK($O142), """", 4*MIN(10,$O142) + 2*MAX(0,MIN(10,$O142-10)) + 1*MAX(0,$O142-20))","=IF(ISBLANK($O142), """", $O142*30)"
Sodium zirconium cyclosilicate,PO,10 g PO TID ×48h then daily,TID then daily,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O143), """", $O143*1.0)","=IF(ISBLANK($O143), """", $O143*1.5)","=IF(ISBLANK($O143), """", $O143*2.0)","=IF(ISBLANK($O143), """", 4*MIN(10,$O143) + 2*MAX(0,MIN(10,$O143-10)) + 1*MAX(0,$O143-20))","=IF(ISBLANK($O143), """", $O143*30)"
Patiromer,PO,8.4–25.2 g PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O144), """", $O144*1.0)","=IF(ISBLANK($O144), """", $O144*1.5)","=IF(ISBLANK($O144), """", $O144*2.0)","=IF(ISBLANK($O144), """", 4*MIN(10,$O144) + 2*MAX(0,MIN(10,$O144-10)) + 1*MAX(0,$O144-20))","=IF(ISBLANK($O144), """", $O144*30)"
Aluminum/magnesium/simethicone,PO,15–30 mL PO q6h PRN,q6h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O145), """", $O145*1.0)","=IF(ISBLANK($O145), """", $O145*1.5)","=IF(ISBLANK($O145), """", $O145*2.0)","=IF(ISBLANK($O145), """", 4*MIN(10,$O145) + 2*MAX(0,MIN(10,$O145-10)) + 1*MAX(0,$O145-20))","=IF(ISBLANK($O145), """", $O145*30)"
Bisacodyl,"PO, PR",5–10 mg PO daily or 10 mg PR daily,Daily,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O146), """", $O146*1.0)","=IF(ISBLANK($O146), """", $O146*1.5)","=IF(ISBLANK($O146), """", $O146*2.0)","=IF(ISBLANK($O146), """", 4*MIN(10,$O146) + 2*MAX(0,MIN(10,$O146-10)) + 1*MAX(0,$O146-20))","=IF(ISBLANK($O146), """", $O146*30)"
Polyethylene glycol,PO,17 g PO q24h (up to BID),q24h,—,—,0.4–1 g/kg/day (max 17 g/day typical),Adolescent up to 17 g/day,No adjustment,No adjustment,,,,,,"=IF(ISBLANK($O147), """", $O147*1.0)","=IF(ISBLANK($O147), """", $O147*1.5)","=IF(ISBLANK($O147), """", $O147*2.0)","=IF(ISBLANK($O147), """", 4*MIN(10,$O147) + 2*MAX(0,MIN(10,$O147-10)) + 1*MAX(0,$O147-20))","=IF(ISBLANK($O147), """", $O147*30)"
Senna,PO,8.6–17.2 mg PO qHS (up to BID),HS/BID,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O148), """", $O148*1.0)","=IF(ISBLANK($O148), """", $O148*1.5)","=IF(ISBLANK($O148), """", $O148*2.0)","=IF(ISBLANK($O148), """", 4*MIN(10,$O148) + 2*MAX(0,MIN(10,$O148-10)) + 1*MAX(0,$O148-20))","=IF(ISBLANK($O148), """", $O148*30)"
Docusate,PO,100 mg PO BID,BID,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O149), """", $O149*1.0)","=IF(ISBLANK($O149), """", $O149*1.5)","=IF(ISBLANK($O149), """", $O149*2.0)","=IF(ISBLANK($O149), """", 4*MIN(10,$O149) + 2*MAX(0,MIN(10,$O149-10)) + 1*MAX(0,$O149-20))","=IF(ISBLANK($O149), """", $O149*30)"
Cholecalciferol (Vitamin D3),PO,"1,000–4,000 units PO q24h (repletion protocols vary)",q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O150), """", $O150*1.0)","=IF(ISBLANK($O150), """", $O150*1.5)","=IF(ISBLANK($O150), """", $O150*2.0)","=IF(ISBLANK($O150), """", 4*MIN(10,$O150) + 2*MAX(0,MIN(10,$O150-10)) + 1*MAX(0,$O150-20))","=IF(ISBLANK($O150), """", $O150*30)"
Calcitriol,PO,0.25–0.5 mcg PO q24–48h,q24–48h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O151), """", $O151*1.0)","=IF(ISBLANK($O151), """", $O151*1.5)","=IF(ISBLANK($O151), """", $O151*2.0)","=IF(ISBLANK($O151), """", 4*MIN(10,$O151) + 2*MAX(0,MIN(10,$O151-10)) + 1*MAX(0,$O151-20))","=IF(ISBLANK($O151), """", $O151*30)"
Sevelamer carbonate,PO,"800–1,600 mg PO TID with meals",TID with meals,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O152), """", $O152*1.0)","=IF(ISBLANK($O152), """", $O152*1.5)","=IF(ISBLANK($O152), """", $O152*2.0)","=IF(ISBLANK($O152), """", 4*MIN(10,$O152) + 2*MAX(0,MIN(10,$O152-10)) + 1*MAX(0,$O152-20))","=IF(ISBLANK($O152), """", $O152*30)"
Sodium polystyrene sulfonate,"PO, PR",15–60 g PO/PR q6h PRN (use with caution),q6h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O153), """", $O153*1.0)","=IF(ISBLANK($O153), """", $O153*1.5)","=IF(ISBLANK($O153), """", $O153*2.0)","=IF(ISBLANK($O153), """", 4*MIN(10,$O153) + 2*MAX(0,MIN(10,$O153-10)) + 1*MAX(0,$O153-20))","=IF(ISBLANK($O153), """", $O153*30)"
Ticagrelor,PO,90 mg PO q12h (load 180 mg),q12h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O154), """", $O154*1.0)","=IF(ISBLANK($O154), """", $O154*1.5)","=IF(ISBLANK($O154), """", $O154*2.0)","=IF(ISBLANK($O154), """", 4*MIN(10,$O154) + 2*MAX(0,MIN(10,$O154-10)) + 1*MAX(0,$O154-20))","=IF(ISBLANK($O154), """", $O154*30)"
Prasugrel,PO,10 mg PO q24h (load 60 mg),q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O155), """", $O155*1.0)","=IF(ISBLANK($O155), """", $O155*1.5)","=IF(ISBLANK($O155), """", $O155*2.0)","=IF(ISBLANK($O155), """", 4*MIN(10,$O155) + 2*MAX(0,MIN(10,$O155-10)) + 1*MAX(0,$O155-20))","=IF(ISBLANK($O155), """", $O155*30)"
Atorvastatin,PO,10–80 mg PO q24h (HS),q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O156), """", $O156*1.0)","=IF(ISBLANK($O156), """", $O156*1.5)","=IF(ISBLANK($O156), """", $O156*2.0)","=IF(ISBLANK($O156), """", 4*MIN(10,$O156) + 2*MAX(0,MIN(10,$O156-10)) + 1*MAX(0,$O156-20))","=IF(ISBLANK($O156), """", $O156*30)"
Rosuvastatin,PO,5–40 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O157), """", $O157*1.0)","=IF(ISBLANK($O157), """", $O157*1.5)","=IF(ISBLANK($O157), """", $O157*2.0)","=IF(ISBLANK($O157), """", 4*MIN(10,$O157) + 2*MAX(0,MIN(10,$O157-10)) + 1*MAX(0,$O157-20))","=IF(ISBLANK($O157), """", $O157*30)"
Ezetimibe,PO,10 mg PO q24h,q24h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O158), """", $O158*1.0)","=IF(ISBLANK($O158), """", $O158*1.5)","=IF(ISBLANK($O158), """", $O158*2.0)","=IF(ISBLANK($O158), """", 4*MIN(10,$O158) + 2*MAX(0,MIN(10,$O158-10)) + 1*MAX(0,$O158-20))","=IF(ISBLANK($O158), """", $O158*30)"
Acetylcysteine (IV),IV,150 mg/kg load then 50 mg/kg over 4 h then 100 mg/kg over 16 h,Protocol,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O159), """", $O159*1.0)","=IF(ISBLANK($O159), """", $O159*1.5)","=IF(ISBLANK($O159), """", $O159*2.0)","=IF(ISBLANK($O159), """", 4*MIN(10,$O159) + 2*MAX(0,MIN(10,$O159-10)) + 1*MAX(0,$O159-20))","=IF(ISBLANK($O159), """", $O159*30)"
Terbutaline,SC,0.25 mg SC q20 min ×3 PRN bronchospasm,PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O160), """", $O160*1.0)","=IF(ISBLANK($O160), """", $O160*1.5)","=IF(ISBLANK($O160), """", $O160*2.0)","=IF(ISBLANK($O160), """", 4*MIN(10,$O160) + 2*MAX(0,MIN(10,$O160-10)) + 1*MAX(0,$O160-20))","=IF(ISBLANK($O160), """", $O160*30)"
Ipratropium‑albuterol (Duoneb),INH,3 mL neb q6h,q6h,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O161), """", $O161*1.0)","=IF(ISBLANK($O161), """", $O161*1.5)","=IF(ISBLANK($O161), """", $O161*2.0)","=IF(ISBLANK($O161), """", 4*MIN(10,$O161) + 2*MAX(0,MIN(10,$O161-10)) + 1*MAX(0,$O161-20))","=IF(ISBLANK($O161), """", $O161*30)"
Guaifenesin,PO,200–400 mg PO q4h PRN (ER 600–1200 mg q12h),q4–12h PRN,—,—,—,—,Check CrCl/eGFR; many agents require dose/interval adjustment; post-HD dosing for dialyzable meds,Use Child-Pugh guidance when applicable; reduce or avoid in severe hepatic impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O162), """", $O162*1.0)","=IF(ISBLANK($O162), """", $O162*1.5)","=IF(ISBLANK($O162), """", $O162*2.0)","=IF(ISBLANK($O162), """", 4*MIN(10,$O162) + 2*MAX(0,MIN(10,$O162-10)) + 1*MAX(0,$O162-20))","=IF(ISBLANK($O162), """", $O162*30)"
Oxygen via nasal cannula,INH,1–6 L/min (titrate to SpO2 target),Continuous/PRN,0.1–2 L/min (blend FiO2 per NICU),0.25–2 L/min,1–4 L/min,1–6 L/min,,,—,—,—,—,,"=IF(ISBLANK($O163), """", $O163*1.0)","=IF(ISBLANK($O163), """", $O163*1.5)","=IF(ISBLANK($O163), """", $O163*2.0)","=IF(ISBLANK($O163), """", 4*MIN(10,$O163) + 2*MAX(0,MIN(10,$O163-10)) + 1*MAX(0,$O163-20))","=IF(ISBLANK($O163), """", $O163*30)"
Oxygen via simple face mask,INH,6–10 L/min,Continuous,,,,,,,—,—,—,—,,"=IF(ISBLANK($O164), """", $O164*1.0)","=IF(ISBLANK($O164), """", $O164*1.5)","=IF(ISBLANK($O164), """", $O164*2.0)","=IF(ISBLANK($O164), """", 4*MIN(10,$O164) + 2*MAX(0,MIN(10,$O164-10)) + 1*MAX(0,$O164-20))","=IF(ISBLANK($O164), """", $O164*30)"
High-flow nasal cannula (HFNC),INH,30–60 L/min; FiO2 0.21–1.0,Continuous (RT protocol),,,,,,,—,—,—,—,,"=IF(ISBLANK($O165), """", $O165*1.0)","=IF(ISBLANK($O165), """", $O165*1.5)","=IF(ISBLANK($O165), """", $O165*2.0)","=IF(ISBLANK($O165), """", 4*MIN(10,$O165) + 2*MAX(0,MIN(10,$O165-10)) + 1*MAX(0,$O165-20))","=IF(ISBLANK($O165), """", $O165*30)"
Incentive spirometry,Device,10 breaths q1–2h while awake,q1–2h while awake,,,,,,,—,—,—,—,,"=IF(ISBLANK($O166), """", $O166*1.0)","=IF(ISBLANK($O166), """", $O166*1.5)","=IF(ISBLANK($O166), """", $O166*2.0)","=IF(ISBLANK($O166), """", 4*MIN(10,$O166) + 2*MAX(0,MIN(10,$O166-10)) + 1*MAX(0,$O166-20))","=IF(ISBLANK($O166), """", $O166*30)"
Chest physiotherapy (RT),Procedure,"Per RT eval (e.g., q6–8h)",q6–8h,,,,,,,—,—,—,—,,"=IF(ISBLANK($O167), """", $O167*1.0)","=IF(ISBLANK($O167), """", $O167*1.5)","=IF(ISBLANK($O167), """", $O167*2.0)","=IF(ISBLANK($O167), """", 4*MIN(10,$O167) + 2*MAX(0,MIN(10,$O167-10)) + 1*MAX(0,$O167-20))","=IF(ISBLANK($O167), """", $O167*30)"
Hypertonic saline 3% (neb),INH,4 mL neb q6–8h PRN,q6–8h PRN,,2–4 mL neb q6–8h PRN (institutional),4 mL neb q6–8h PRN,4 mL neb q6–8h PRN,,,—,—,—,—,,"=IF(ISBLANK($O168), """", $O168*1.0)","=IF(ISBLANK($O168), """", $O168*1.5)","=IF(ISBLANK($O168), """", $O168*2.0)","=IF(ISBLANK($O168), """", 4*MIN(10,$O168) + 2*MAX(0,MIN(10,$O168-10)) + 1*MAX(0,$O168-20))","=IF(ISBLANK($O168), """", $O168*30)"
Racemic epinephrine (neb),INH,0.5 mL of 2.25% in 3 mL NS neb q20min PRN,PRN,,0.5 mL of 2.25% in 3 mL NS neb; observe rebound,Same,Same,,,—,—,—,—,,"=IF(ISBLANK($O169), """", $O169*1.0)","=IF(ISBLANK($O169), """", $O169*1.5)","=IF(ISBLANK($O169), """", $O169*2.0)","=IF(ISBLANK($O169), """", 4*MIN(10,$O169) + 2*MAX(0,MIN(10,$O169-10)) + 1*MAX(0,$O169-20))","=IF(ISBLANK($O169), """", $O169*30)"
Albuterol HFA (inhaler),INH,2 puffs q4–6h PRN (spacer),q4–6h PRN,,1–2 puffs q4–6h PRN (spacer),2 puffs q4–6h PRN (spacer),2 puffs q4–6h PRN,,,—,—,—,—,,"=IF(ISBLANK($O170), """", $O170*1.0)","=IF(ISBLANK($O170), """", $O170*1.5)","=IF(ISBLANK($O170), """", $O170*2.0)","=IF(ISBLANK($O170), """", 4*MIN(10,$O170) + 2*MAX(0,MIN(10,$O170-10)) + 1*MAX(0,$O170-20))","=IF(ISBLANK($O170), """", $O170*30)"
Ipratropium HFA (inhaler),INH,2 puffs q6h,q6h,,,,,,,—,—,—,—,,"=IF(ISBLANK($O171), """", $O171*1.0)","=IF(ISBLANK($O171), """", $O171*1.5)","=IF(ISBLANK($O171), """", $O171*2.0)","=IF(ISBLANK($O171), """", 4*MIN(10,$O171) + 2*MAX(0,MIN(10,$O171-10)) + 1*MAX(0,$O171-20))","=IF(ISBLANK($O171), """", $O171*30)"
Budesonide-formoterol (inhaler),INH,160/4.5 mcg: 2 puffs q12h (SMART varies),q12h (or SMART),,,80/4.5: 2 puffs q12h (formulary dependent),160/4.5: 2 puffs q12h,,,—,—,—,—,,"=IF(ISBLANK($O172), """", $O172*1.0)","=IF(ISBLANK($O172), """", $O172*1.5)","=IF(ISBLANK($O172), """", $O172*2.0)","=IF(ISBLANK($O172), """", 4*MIN(10,$O172) + 2*MAX(0,MIN(10,$O172-10)) + 1*MAX(0,$O172-20))","=IF(ISBLANK($O172), """", $O172*30)"
Fluticasone-salmeterol (inhaler),INH,1 puff q12h (strength per patient),q12h,,,,,,,—,—,—,—,,"=IF(ISBLANK($O173), """", $O173*1.0)","=IF(ISBLANK($O173), """", $O173*1.5)","=IF(ISBLANK($O173), """", $O173*2.0)","=IF(ISBLANK($O173), """", 4*MIN(10,$O173) + 2*MAX(0,MIN(10,$O173-10)) + 1*MAX(0,$O173-20))","=IF(ISBLANK($O173), """", $O173*30)"
Tiotropium (inhaler),INH,2 inhalations q24h (Respimat),q24h,,,,,,,—,—,—,—,,"=IF(ISBLANK($O174), """", $O174*1.0)","=IF(ISBLANK($O174), """", $O174*1.5)","=IF(ISBLANK($O174), """", $O174*2.0)","=IF(ISBLANK($O174), """", 4*MIN(10,$O174) + 2*MAX(0,MIN(10,$O174-10)) + 1*MAX(0,$O174-20))","=IF(ISBLANK($O174), """", $O174*30)"
Fluticasone (inhaled),INH,100–250 mcg BID (titrate),BID,,,44–110 mcg BID (device dependent),110–220 mcg BID,,,—,—,—,—,,"=IF(ISBLANK($O175), """", $O175*1.0)","=IF(ISBLANK($O175), """", $O175*1.5)","=IF(ISBLANK($O175), """", $O175*2.0)","=IF(ISBLANK($O175), """", 4*MIN(10,$O175) + 2*MAX(0,MIN(10,$O175-10)) + 1*MAX(0,$O175-20))","=IF(ISBLANK($O175), """", $O175*30)"
Umeclidinium-vilanterol (inhaler),INH,1 inhalation q24h,q24h,,,,,,,—,—,—,—,,"=IF(ISBLANK($O176), """", $O176*1.0)","=IF(ISBLANK($O176), """", $O176*1.5)","=IF(ISBLANK($O176), """", $O176*2.0)","=IF(ISBLANK($O176), """", 4*MIN(10,$O176) + 2*MAX(0,MIN(10,$O176-10)) + 1*MAX(0,$O176-20))","=IF(ISBLANK($O176), """", $O176*30)"
Saline nasal spray 0.65%,IN,2 sprays/nostril q4–6h PRN,q4–6h PRN,,,,,,,—,—,—,—,,"=IF(ISBLANK($O177), """", $O177*1.0)","=IF(ISBLANK($O177), """", $O177*1.5)","=IF(ISBLANK($O177), """", $O177*2.0)","=IF(ISBLANK($O177), """", 4*MIN(10,$O177) + 2*MAX(0,MIN(10,$O177-10)) + 1*MAX(0,$O177-20))","=IF(ISBLANK($O177), """", $O177*30)"
Ramelteon,PO,8 mg PO qHS,HS,,,,,,,—,—,—,—,,"=IF(ISBLANK($O178), """", $O178*1.0)","=IF(ISBLANK($O178), """", $O178*1.5)","=IF(ISBLANK($O178), """", $O178*2.0)","=IF(ISBLANK($O178), """", 4*MIN(10,$O178) + 2*MAX(0,MIN(10,$O178-10)) + 1*MAX(0,$O178-20))","=IF(ISBLANK($O178), """", $O178*30)"
Ampicillin,"IV, PO",1–2 g IV q4–6h; PO 500 mg q6h,q4–6h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O179), """", $O179*1.0)","=IF(ISBLANK($O179), """", $O179*1.5)","=IF(ISBLANK($O179), """", $O179*2.0)","=IF(ISBLANK($O179), """", 4*MIN(10,$O179) + 2*MAX(0,MIN(10,$O179-10)) + 1*MAX(0,$O179-20))","=IF(ISBLANK($O179), """", $O179*30)"
Penicillin G (aqueous),IV,2–4 million units IV q4h (indication-based),q4h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O180), """", $O180*1.0)","=IF(ISBLANK($O180), """", $O180*1.5)","=IF(ISBLANK($O180), """", $O180*2.0)","=IF(ISBLANK($O180), """", 4*MIN(10,$O180) + 2*MAX(0,MIN(10,$O180-10)) + 1*MAX(0,$O180-20))","=IF(ISBLANK($O180), """", $O180*30)"
Penicillin VK,PO,250–500 mg PO q6h,q6h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O181), """", $O181*1.0)","=IF(ISBLANK($O181), """", $O181*1.5)","=IF(ISBLANK($O181), """", $O181*2.0)","=IF(ISBLANK($O181), """", 4*MIN(10,$O181) + 2*MAX(0,MIN(10,$O181-10)) + 1*MAX(0,$O181-20))","=IF(ISBLANK($O181), """", $O181*30)"
Azithromycin,"IV, PO",500 mg daily (first day) then 250 mg q24h ×4 days,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O182), """", $O182*1.0)","=IF(ISBLANK($O182), """", $O182*1.5)","=IF(ISBLANK($O182), """", $O182*2.0)","=IF(ISBLANK($O182), """", 4*MIN(10,$O182) + 2*MAX(0,MIN(10,$O182-10)) + 1*MAX(0,$O182-20))","=IF(ISBLANK($O182), """", $O182*30)"
Doxycycline,"IV, PO",100 mg q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O183), """", $O183*1.0)","=IF(ISBLANK($O183), """", $O183*1.5)","=IF(ISBLANK($O183), """", $O183*2.0)","=IF(ISBLANK($O183), """", 4*MIN(10,$O183) + 2*MAX(0,MIN(10,$O183-10)) + 1*MAX(0,$O183-20))","=IF(ISBLANK($O183), """", $O183*30)"
Minocycline,"IV, PO",100 mg q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O184), """", $O184*1.0)","=IF(ISBLANK($O184), """", $O184*1.5)","=IF(ISBLANK($O184), """", $O184*2.0)","=IF(ISBLANK($O184), """", 4*MIN(10,$O184) + 2*MAX(0,MIN(10,$O184-10)) + 1*MAX(0,$O184-20))","=IF(ISBLANK($O184), """", $O184*30)"
Tigecycline,IV,100 mg load then 50 mg q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O185), """", $O185*1.0)","=IF(ISBLANK($O185), """", $O185*1.5)","=IF(ISBLANK($O185), """", $O185*2.0)","=IF(ISBLANK($O185), """", 4*MIN(10,$O185) + 2*MAX(0,MIN(10,$O185-10)) + 1*MAX(0,$O185-20))","=IF(ISBLANK($O185), """", $O185*30)"
Ceftaroline,IV,600 mg IV q12h (q8h in severe MRSA),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O186), """", $O186*1.0)","=IF(ISBLANK($O186), """", $O186*1.5)","=IF(ISBLANK($O186), """", $O186*2.0)","=IF(ISBLANK($O186), """", 4*MIN(10,$O186) + 2*MAX(0,MIN(10,$O186-10)) + 1*MAX(0,$O186-20))","=IF(ISBLANK($O186), """", $O186*30)"
Cefotetan,IV,1–2 g IV q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O187), """", $O187*1.0)","=IF(ISBLANK($O187), """", $O187*1.5)","=IF(ISBLANK($O187), """", $O187*2.0)","=IF(ISBLANK($O187), """", 4*MIN(10,$O187) + 2*MAX(0,MIN(10,$O187-10)) + 1*MAX(0,$O187-20))","=IF(ISBLANK($O187), """", $O187*30)"
Ceftazidime-avibactam,IV,2.5 g IV q8h (CrCl adjust),q8h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O188), """", $O188*1.0)","=IF(ISBLANK($O188), """", $O188*1.5)","=IF(ISBLANK($O188), """", $O188*2.0)","=IF(ISBLANK($O188), """", 4*MIN(10,$O188) + 2*MAX(0,MIN(10,$O188-10)) + 1*MAX(0,$O188-20))","=IF(ISBLANK($O188), """", $O188*30)"
Ceftolozane-tazobactam,IV,1.5–3 g IV q8h (CrCl adjust),q8h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O189), """", $O189*1.0)","=IF(ISBLANK($O189), """", $O189*1.5)","=IF(ISBLANK($O189), """", $O189*2.0)","=IF(ISBLANK($O189), """", 4*MIN(10,$O189) + 2*MAX(0,MIN(10,$O189-10)) + 1*MAX(0,$O189-20))","=IF(ISBLANK($O189), """", $O189*30)"
Meropenem-vaborbactam,IV,4 g IV q8h (3-h infusion; CrCl adjust),q8h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O190), """", $O190*1.0)","=IF(ISBLANK($O190), """", $O190*1.5)","=IF(ISBLANK($O190), """", $O190*2.0)","=IF(ISBLANK($O190), """", 4*MIN(10,$O190) + 2*MAX(0,MIN(10,$O190-10)) + 1*MAX(0,$O190-20))","=IF(ISBLANK($O190), """", $O190*30)"
Imipenem-cilastatin-relebactam,IV,1.25 g IV q6h (CrCl adjust),q6h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O191), """", $O191*1.0)","=IF(ISBLANK($O191), """", $O191*1.5)","=IF(ISBLANK($O191), """", $O191*2.0)","=IF(ISBLANK($O191), """", 4*MIN(10,$O191) + 2*MAX(0,MIN(10,$O191-10)) + 1*MAX(0,$O191-20))","=IF(ISBLANK($O191), """", $O191*30)"
Telavancin,IV,10 mg/kg IV q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O192), """", $O192*1.0)","=IF(ISBLANK($O192), """", $O192*1.5)","=IF(ISBLANK($O192), """", $O192*2.0)","=IF(ISBLANK($O192), """", 4*MIN(10,$O192) + 2*MAX(0,MIN(10,$O192-10)) + 1*MAX(0,$O192-20))","=IF(ISBLANK($O192), """", $O192*30)"
Dalbavancin,IV,"1,500 mg once (or 1,000 mg then 500 mg 1 week later)",Once/weekly,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O193), """", $O193*1.0)","=IF(ISBLANK($O193), """", $O193*1.5)","=IF(ISBLANK($O193), """", $O193*2.0)","=IF(ISBLANK($O193), """", 4*MIN(10,$O193) + 2*MAX(0,MIN(10,$O193-10)) + 1*MAX(0,$O193-20))","=IF(ISBLANK($O193), """", $O193*30)"
Oritavancin,IV,"1,200 mg IV once",Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O194), """", $O194*1.0)","=IF(ISBLANK($O194), """", $O194*1.5)","=IF(ISBLANK($O194), """", $O194*2.0)","=IF(ISBLANK($O194), """", 4*MIN(10,$O194) + 2*MAX(0,MIN(10,$O194-10)) + 1*MAX(0,$O194-20))","=IF(ISBLANK($O194), """", $O194*30)"
Daptomycin (high dose),IV,8–10 mg/kg q24h (endocarditis),q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O195), """", $O195*1.0)","=IF(ISBLANK($O195), """", $O195*1.5)","=IF(ISBLANK($O195), """", $O195*2.0)","=IF(ISBLANK($O195), """", 4*MIN(10,$O195) + 2*MAX(0,MIN(10,$O195-10)) + 1*MAX(0,$O195-20))","=IF(ISBLANK($O195), """", $O195*30)"
Nitrofurantoin,PO,100 mg PO q12h (avoid CrCl<30),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O196), """", $O196*1.0)","=IF(ISBLANK($O196), """", $O196*1.5)","=IF(ISBLANK($O196), """", $O196*2.0)","=IF(ISBLANK($O196), """", 4*MIN(10,$O196) + 2*MAX(0,MIN(10,$O196-10)) + 1*MAX(0,$O196-20))","=IF(ISBLANK($O196), """", $O196*30)"
Fosfomycin (PO),PO,3 g PO single dose (uncomplicated cystitis),Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O197), """", $O197*1.0)","=IF(ISBLANK($O197), """", $O197*1.5)","=IF(ISBLANK($O197), """", $O197*2.0)","=IF(ISBLANK($O197), """", 4*MIN(10,$O197) + 2*MAX(0,MIN(10,$O197-10)) + 1*MAX(0,$O197-20))","=IF(ISBLANK($O197), """", $O197*30)"
Ganciclovir,IV,5 mg/kg IV q12h (induction),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O198), """", $O198*1.0)","=IF(ISBLANK($O198), """", $O198*1.5)","=IF(ISBLANK($O198), """", $O198*2.0)","=IF(ISBLANK($O198), """", 4*MIN(10,$O198) + 2*MAX(0,MIN(10,$O198-10)) + 1*MAX(0,$O198-20))","=IF(ISBLANK($O198), """", $O198*30)"
Valganciclovir,PO,900 mg PO q12h (induction),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O199), """", $O199*1.0)","=IF(ISBLANK($O199), """", $O199*1.5)","=IF(ISBLANK($O199), """", $O199*2.0)","=IF(ISBLANK($O199), """", 4*MIN(10,$O199) + 2*MAX(0,MIN(10,$O199-10)) + 1*MAX(0,$O199-20))","=IF(ISBLANK($O199), """", $O199*30)"
Foscarnet,IV,40 mg/kg IV q8–12h (induction; monitor lytes),q8–12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O200), """", $O200*1.0)","=IF(ISBLANK($O200), """", $O200*1.5)","=IF(ISBLANK($O200), """", $O200*2.0)","=IF(ISBLANK($O200), """", 4*MIN(10,$O200) + 2*MAX(0,MIN(10,$O200-10)) + 1*MAX(0,$O200-20))","=IF(ISBLANK($O200), """", $O200*30)"
Peramivir,IV,600 mg IV once (influenza),Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O201), """", $O201*1.0)","=IF(ISBLANK($O201), """", $O201*1.5)","=IF(ISBLANK($O201), """", $O201*2.0)","=IF(ISBLANK($O201), """", 4*MIN(10,$O201) + 2*MAX(0,MIN(10,$O201-10)) + 1*MAX(0,$O201-20))","=IF(ISBLANK($O201), """", $O201*30)"
Remdesivir,IV,200 mg load then 100 mg IV q24h ×4,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O202), """", $O202*1.0)","=IF(ISBLANK($O202), """", $O202*1.5)","=IF(ISBLANK($O202), """", $O202*2.0)","=IF(ISBLANK($O202), """", 4*MIN(10,$O202) + 2*MAX(0,MIN(10,$O202-10)) + 1*MAX(0,$O202-20))","=IF(ISBLANK($O202), """", $O202*30)"
Caspofungin,IV,70 mg load then 50 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O203), """", $O203*1.0)","=IF(ISBLANK($O203), """", $O203*1.5)","=IF(ISBLANK($O203), """", $O203*2.0)","=IF(ISBLANK($O203), """", 4*MIN(10,$O203) + 2*MAX(0,MIN(10,$O203-10)) + 1*MAX(0,$O203-20))","=IF(ISBLANK($O203), """", $O203*30)"
Anidulafungin,IV,200 mg load then 100 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O204), """", $O204*1.0)","=IF(ISBLANK($O204), """", $O204*1.5)","=IF(ISBLANK($O204), """", $O204*2.0)","=IF(ISBLANK($O204), """", 4*MIN(10,$O204) + 2*MAX(0,MIN(10,$O204-10)) + 1*MAX(0,$O204-20))","=IF(ISBLANK($O204), """", $O204*30)"
Posaconazole,"IV, PO",300 mg BID day 1 then 300 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O205), """", $O205*1.0)","=IF(ISBLANK($O205), """", $O205*1.5)","=IF(ISBLANK($O205), """", $O205*2.0)","=IF(ISBLANK($O205), """", 4*MIN(10,$O205) + 2*MAX(0,MIN(10,$O205-10)) + 1*MAX(0,$O205-20))","=IF(ISBLANK($O205), """", $O205*30)"
Isavuconazonium,"IV, PO",372 mg q8h ×6 doses then 372 mg q24h,q8–24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O206), """", $O206*1.0)","=IF(ISBLANK($O206), """", $O206*1.5)","=IF(ISBLANK($O206), """", $O206*2.0)","=IF(ISBLANK($O206), """", 4*MIN(10,$O206) + 2*MAX(0,MIN(10,$O206-10)) + 1*MAX(0,$O206-20))","=IF(ISBLANK($O206), """", $O206*30)"
Esmolol infusion,IV,50–200 mcg/kg/min titrated,Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O207), """", $O207*1.0)","=IF(ISBLANK($O207), """", $O207*1.5)","=IF(ISBLANK($O207), """", $O207*2.0)","=IF(ISBLANK($O207), """", 4*MIN(10,$O207) + 2*MAX(0,MIN(10,$O207-10)) + 1*MAX(0,$O207-20))","=IF(ISBLANK($O207), """", $O207*30)"
Clevidipine,IV,1–21 mg/h titrated,Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O208), """", $O208*1.0)","=IF(ISBLANK($O208), """", $O208*1.5)","=IF(ISBLANK($O208), """", $O208*2.0)","=IF(ISBLANK($O208), """", 4*MIN(10,$O208) + 2*MAX(0,MIN(10,$O208-10)) + 1*MAX(0,$O208-20))","=IF(ISBLANK($O208), """", $O208*30)"
Nitroprusside,IV,0.3–10 mcg/kg/min titrated,Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O209), """", $O209*1.0)","=IF(ISBLANK($O209), """", $O209*1.5)","=IF(ISBLANK($O209), """", $O209*2.0)","=IF(ISBLANK($O209), """", 4*MIN(10,$O209) + 2*MAX(0,MIN(10,$O209-10)) + 1*MAX(0,$O209-20))","=IF(ISBLANK($O209), """", $O209*30)"
Dobutamine,IV,2–20 mcg/kg/min titrated,Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O210), """", $O210*1.0)","=IF(ISBLANK($O210), """", $O210*1.5)","=IF(ISBLANK($O210), """", $O210*2.0)","=IF(ISBLANK($O210), """", 4*MIN(10,$O210) + 2*MAX(0,MIN(10,$O210-10)) + 1*MAX(0,$O210-20))","=IF(ISBLANK($O210), """", $O210*30)"
Dopamine,IV,2–20 mcg/kg/min titrated,Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O211), """", $O211*1.0)","=IF(ISBLANK($O211), """", $O211*1.5)","=IF(ISBLANK($O211), """", $O211*2.0)","=IF(ISBLANK($O211), """", 4*MIN(10,$O211) + 2*MAX(0,MIN(10,$O211-10)) + 1*MAX(0,$O211-20))","=IF(ISBLANK($O211), """", $O211*30)"
Milrinone,IV,0.125–0.75 mcg/kg/min (load optional),Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O212), """", $O212*1.0)","=IF(ISBLANK($O212), """", $O212*1.5)","=IF(ISBLANK($O212), """", $O212*2.0)","=IF(ISBLANK($O212), """", 4*MIN(10,$O212) + 2*MAX(0,MIN(10,$O212-10)) + 1*MAX(0,$O212-20))","=IF(ISBLANK($O212), """", $O212*30)"
Digoxin,"IV, PO","Load 8–12 mcg/kg (IV), maintenance 0.125–0.25 mg q24h",q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O213), """", $O213*1.0)","=IF(ISBLANK($O213), """", $O213*1.5)","=IF(ISBLANK($O213), """", $O213*2.0)","=IF(ISBLANK($O213), """", 4*MIN(10,$O213) + 2*MAX(0,MIN(10,$O213-10)) + 1*MAX(0,$O213-20))","=IF(ISBLANK($O213), """", $O213*30)"
Lisinopril,PO,5–40 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O214), """", $O214*1.0)","=IF(ISBLANK($O214), """", $O214*1.5)","=IF(ISBLANK($O214), """", $O214*2.0)","=IF(ISBLANK($O214), """", 4*MIN(10,$O214) + 2*MAX(0,MIN(10,$O214-10)) + 1*MAX(0,$O214-20))","=IF(ISBLANK($O214), """", $O214*30)"
Enalapril,PO,5–20 mg q12–24h,q12–24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O215), """", $O215*1.0)","=IF(ISBLANK($O215), """", $O215*1.5)","=IF(ISBLANK($O215), """", $O215*2.0)","=IF(ISBLANK($O215), """", 4*MIN(10,$O215) + 2*MAX(0,MIN(10,$O215-10)) + 1*MAX(0,$O215-20))","=IF(ISBLANK($O215), """", $O215*30)"
Captopril,PO,12.5–50 mg q8h,q8h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O216), """", $O216*1.0)","=IF(ISBLANK($O216), """", $O216*1.5)","=IF(ISBLANK($O216), """", $O216*2.0)","=IF(ISBLANK($O216), """", 4*MIN(10,$O216) + 2*MAX(0,MIN(10,$O216-10)) + 1*MAX(0,$O216-20))","=IF(ISBLANK($O216), """", $O216*30)"
Losartan,PO,25–100 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O217), """", $O217*1.0)","=IF(ISBLANK($O217), """", $O217*1.5)","=IF(ISBLANK($O217), """", $O217*2.0)","=IF(ISBLANK($O217), """", 4*MIN(10,$O217) + 2*MAX(0,MIN(10,$O217-10)) + 1*MAX(0,$O217-20))","=IF(ISBLANK($O217), """", $O217*30)"
Valsartan,PO,80–320 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O218), """", $O218*1.0)","=IF(ISBLANK($O218), """", $O218*1.5)","=IF(ISBLANK($O218), """", $O218*2.0)","=IF(ISBLANK($O218), """", 4*MIN(10,$O218) + 2*MAX(0,MIN(10,$O218-10)) + 1*MAX(0,$O218-20))","=IF(ISBLANK($O218), """", $O218*30)"
Amlodipine,PO,2.5–10 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O219), """", $O219*1.0)","=IF(ISBLANK($O219), """", $O219*1.5)","=IF(ISBLANK($O219), """", $O219*2.0)","=IF(ISBLANK($O219), """", 4*MIN(10,$O219) + 2*MAX(0,MIN(10,$O219-10)) + 1*MAX(0,$O219-20))","=IF(ISBLANK($O219), """", $O219*30)"
Nifedipine ER,PO,30–90 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O220), """", $O220*1.0)","=IF(ISBLANK($O220), """", $O220*1.5)","=IF(ISBLANK($O220), """", $O220*2.0)","=IF(ISBLANK($O220), """", 4*MIN(10,$O220) + 2*MAX(0,MIN(10,$O220-10)) + 1*MAX(0,$O220-20))","=IF(ISBLANK($O220), """", $O220*30)"
Isosorbide mononitrate ER,PO,30–120 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O221), """", $O221*1.0)","=IF(ISBLANK($O221), """", $O221*1.5)","=IF(ISBLANK($O221), """", $O221*2.0)","=IF(ISBLANK($O221), """", 4*MIN(10,$O221) + 2*MAX(0,MIN(10,$O221-10)) + 1*MAX(0,$O221-20))","=IF(ISBLANK($O221), """", $O221*30)"
Isosorbide dinitrate,PO,10–40 mg q8–12h,q8–12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O222), """", $O222*1.0)","=IF(ISBLANK($O222), """", $O222*1.5)","=IF(ISBLANK($O222), """", $O222*2.0)","=IF(ISBLANK($O222), """", 4*MIN(10,$O222) + 2*MAX(0,MIN(10,$O222-10)) + 1*MAX(0,$O222-20))","=IF(ISBLANK($O222), """", $O222*30)"
Labetalol (PO),PO,100–400 mg q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O223), """", $O223*1.0)","=IF(ISBLANK($O223), """", $O223*1.5)","=IF(ISBLANK($O223), """", $O223*2.0)","=IF(ISBLANK($O223), """", 4*MIN(10,$O223) + 2*MAX(0,MIN(10,$O223-10)) + 1*MAX(0,$O223-20))","=IF(ISBLANK($O223), """", $O223*30)"
Hydralazine (PO),PO,25–100 mg q8h,q8h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O224), """", $O224*1.0)","=IF(ISBLANK($O224), """", $O224*1.5)","=IF(ISBLANK($O224), """", $O224*2.0)","=IF(ISBLANK($O224), """", 4*MIN(10,$O224) + 2*MAX(0,MIN(10,$O224-10)) + 1*MAX(0,$O224-20))","=IF(ISBLANK($O224), """", $O224*30)"
Eptifibatide,IV,180 mcg/kg bolus then 2 mcg/kg/min,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O225), """", $O225*1.0)","=IF(ISBLANK($O225), """", $O225*1.5)","=IF(ISBLANK($O225), """", $O225*2.0)","=IF(ISBLANK($O225), """", 4*MIN(10,$O225) + 2*MAX(0,MIN(10,$O225-10)) + 1*MAX(0,$O225-20))","=IF(ISBLANK($O225), """", $O225*30)"
Tirofiban,IV,25 mcg/kg bolus then 0.15 mcg/kg/min,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O226), """", $O226*1.0)","=IF(ISBLANK($O226), """", $O226*1.5)","=IF(ISBLANK($O226), """", $O226*2.0)","=IF(ISBLANK($O226), """", 4*MIN(10,$O226) + 2*MAX(0,MIN(10,$O226-10)) + 1*MAX(0,$O226-20))","=IF(ISBLANK($O226), """", $O226*30)"
Bivalirudin,IV,0.75 mg/kg bolus then 1.75 mg/kg/h,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O227), """", $O227*1.0)","=IF(ISBLANK($O227), """", $O227*1.5)","=IF(ISBLANK($O227), """", $O227*2.0)","=IF(ISBLANK($O227), """", 4*MIN(10,$O227) + 2*MAX(0,MIN(10,$O227-10)) + 1*MAX(0,$O227-20))","=IF(ISBLANK($O227), """", $O227*30)"
Argatroban,IV,0.5–2 mcg/kg/min (hepatic adjust),Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O228), """", $O228*1.0)","=IF(ISBLANK($O228), """", $O228*1.5)","=IF(ISBLANK($O228), """", $O228*2.0)","=IF(ISBLANK($O228), """", 4*MIN(10,$O228) + 2*MAX(0,MIN(10,$O228-10)) + 1*MAX(0,$O228-20))","=IF(ISBLANK($O228), """", $O228*30)"
Fondaparinux (therap.),SC,5–10 mg SC q24h by weight,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O229), """", $O229*1.0)","=IF(ISBLANK($O229), """", $O229*1.5)","=IF(ISBLANK($O229), """", $O229*2.0)","=IF(ISBLANK($O229), """", 4*MIN(10,$O229) + 2*MAX(0,MIN(10,$O229-10)) + 1*MAX(0,$O229-20))","=IF(ISBLANK($O229), """", $O229*30)"
Dabigatran,PO,150 mg q12h (CrCl-dependent),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O230), """", $O230*1.0)","=IF(ISBLANK($O230), """", $O230*1.5)","=IF(ISBLANK($O230), """", $O230*2.0)","=IF(ISBLANK($O230), """", 4*MIN(10,$O230) + 2*MAX(0,MIN(10,$O230-10)) + 1*MAX(0,$O230-20))","=IF(ISBLANK($O230), """", $O230*30)"
Edoxaban,PO,60 mg q24h (dose-reduce per CrCl/weight),q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O231), """", $O231*1.0)","=IF(ISBLANK($O231), """", $O231*1.5)","=IF(ISBLANK($O231), """", $O231*2.0)","=IF(ISBLANK($O231), """", 4*MIN(10,$O231) + 2*MAX(0,MIN(10,$O231-10)) + 1*MAX(0,$O231-20))","=IF(ISBLANK($O231), """", $O231*30)"
Chlorothiazide,IV,"500–1,000 mg IV q12h",q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O232), """", $O232*1.0)","=IF(ISBLANK($O232), """", $O232*1.5)","=IF(ISBLANK($O232), """", $O232*2.0)","=IF(ISBLANK($O232), """", 4*MIN(10,$O232) + 2*MAX(0,MIN(10,$O232-10)) + 1*MAX(0,$O232-20))","=IF(ISBLANK($O232), """", $O232*30)"
Hydrochlorothiazide,PO,12.5–50 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O233), """", $O233*1.0)","=IF(ISBLANK($O233), """", $O233*1.5)","=IF(ISBLANK($O233), """", $O233*2.0)","=IF(ISBLANK($O233), """", 4*MIN(10,$O233) + 2*MAX(0,MIN(10,$O233-10)) + 1*MAX(0,$O233-20))","=IF(ISBLANK($O233), """", $O233*30)"
Metolazone,PO,2.5–10 mg q24–48h,q24–48h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O234), """", $O234*1.0)","=IF(ISBLANK($O234), """", $O234*1.5)","=IF(ISBLANK($O234), """", $O234*2.0)","=IF(ISBLANK($O234), """", 4*MIN(10,$O234) + 2*MAX(0,MIN(10,$O234-10)) + 1*MAX(0,$O234-20))","=IF(ISBLANK($O234), """", $O234*30)"
Acetazolamide,"IV, PO",250–500 mg q6–12h,q6–12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O235), """", $O235*1.0)","=IF(ISBLANK($O235), """", $O235*1.5)","=IF(ISBLANK($O235), """", $O235*2.0)","=IF(ISBLANK($O235), """", 4*MIN(10,$O235) + 2*MAX(0,MIN(10,$O235-10)) + 1*MAX(0,$O235-20))","=IF(ISBLANK($O235), """", $O235*30)"
Desmopressin (DDAVP),"IV, IN, PO",0.3 mcg/kg IV; IN 10–40 mcg/day divided,Varies,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O236), """", $O236*1.0)","=IF(ISBLANK($O236), """", $O236*1.5)","=IF(ISBLANK($O236), """", $O236*2.0)","=IF(ISBLANK($O236), """", 4*MIN(10,$O236) + 2*MAX(0,MIN(10,$O236-10)) + 1*MAX(0,$O236-20))","=IF(ISBLANK($O236), """", $O236*30)"
Tolvaptan,PO,15–60 mg q24h (monitor Na rise),q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O237), """", $O237*1.0)","=IF(ISBLANK($O237), """", $O237*1.5)","=IF(ISBLANK($O237), """", $O237*2.0)","=IF(ISBLANK($O237), """", 4*MIN(10,$O237) + 2*MAX(0,MIN(10,$O237-10)) + 1*MAX(0,$O237-20))","=IF(ISBLANK($O237), """", $O237*30)"
Conivaptan,IV,20 mg IV load then 20 mg/day,Daily,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O238), """", $O238*1.0)","=IF(ISBLANK($O238), """", $O238*1.5)","=IF(ISBLANK($O238), """", $O238*2.0)","=IF(ISBLANK($O238), """", 4*MIN(10,$O238) + 2*MAX(0,MIN(10,$O238-10)) + 1*MAX(0,$O238-20))","=IF(ISBLANK($O238), """", $O238*30)"
Calcium chloride,IV,1 g IV (central) over 10–20 min,PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O239), """", $O239*1.0)","=IF(ISBLANK($O239), """", $O239*1.5)","=IF(ISBLANK($O239), """", $O239*2.0)","=IF(ISBLANK($O239), """", 4*MIN(10,$O239) + 2*MAX(0,MIN(10,$O239-10)) + 1*MAX(0,$O239-20))","=IF(ISBLANK($O239), """", $O239*30)"
Sodium chloride tablets,PO,1 g PO TID,TID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O240), """", $O240*1.0)","=IF(ISBLANK($O240), """", $O240*1.5)","=IF(ISBLANK($O240), """", $O240*2.0)","=IF(ISBLANK($O240), """", 4*MIN(10,$O240) + 2*MAX(0,MIN(10,$O240-10)) + 1*MAX(0,$O240-20))","=IF(ISBLANK($O240), """", $O240*30)"
Urea (oral packets),PO,15–30 g q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O241), """", $O241*1.0)","=IF(ISBLANK($O241), """", $O241*1.5)","=IF(ISBLANK($O241), """", $O241*2.0)","=IF(ISBLANK($O241), """", 4*MIN(10,$O241) + 2*MAX(0,MIN(10,$O241-10)) + 1*MAX(0,$O241-20))","=IF(ISBLANK($O241), """", $O241*30)"
Insulin NPH,SC,0.1–0.3 units/kg q12h (titrate),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O242), """", $O242*1.0)","=IF(ISBLANK($O242), """", $O242*1.5)","=IF(ISBLANK($O242), """", $O242*2.0)","=IF(ISBLANK($O242), """", 4*MIN(10,$O242) + 2*MAX(0,MIN(10,$O242-10)) + 1*MAX(0,$O242-20))","=IF(ISBLANK($O242), """", $O242*30)"
Insulin regular (SC),SC,AC/HS dosing per scale,AC/HS,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O243), """", $O243*1.0)","=IF(ISBLANK($O243), """", $O243*1.5)","=IF(ISBLANK($O243), """", $O243*2.0)","=IF(ISBLANK($O243), """", 4*MIN(10,$O243) + 2*MAX(0,MIN(10,$O243-10)) + 1*MAX(0,$O243-20))","=IF(ISBLANK($O243), """", $O243*30)"
Insulin detemir,SC,0.1–0.4 units/kg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O244), """", $O244*1.0)","=IF(ISBLANK($O244), """", $O244*1.5)","=IF(ISBLANK($O244), """", $O244*2.0)","=IF(ISBLANK($O244), """", 4*MIN(10,$O244) + 2*MAX(0,MIN(10,$O244-10)) + 1*MAX(0,$O244-20))","=IF(ISBLANK($O244), """", $O244*30)"
Insulin degludec,SC,10–40 units q24h (titrate),q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O245), """", $O245*1.0)","=IF(ISBLANK($O245), """", $O245*1.5)","=IF(ISBLANK($O245), """", $O245*2.0)","=IF(ISBLANK($O245), """", 4*MIN(10,$O245) + 2*MAX(0,MIN(10,$O245-10)) + 1*MAX(0,$O245-20))","=IF(ISBLANK($O245), """", $O245*30)"
Metformin,PO,"500–1,000 mg BID (hold AKI/contrast)",BID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O246), """", $O246*1.0)","=IF(ISBLANK($O246), """", $O246*1.5)","=IF(ISBLANK($O246), """", $O246*2.0)","=IF(ISBLANK($O246), """", 4*MIN(10,$O246) + 2*MAX(0,MIN(10,$O246-10)) + 1*MAX(0,$O246-20))","=IF(ISBLANK($O246), """", $O246*30)"
Glipizide,PO,2.5–10 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O247), """", $O247*1.0)","=IF(ISBLANK($O247), """", $O247*1.5)","=IF(ISBLANK($O247), """", $O247*2.0)","=IF(ISBLANK($O247), """", 4*MIN(10,$O247) + 2*MAX(0,MIN(10,$O247-10)) + 1*MAX(0,$O247-20))","=IF(ISBLANK($O247), """", $O247*30)"
Methimazole,PO,5–30 mg/day divided,q8–24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O248), """", $O248*1.0)","=IF(ISBLANK($O248), """", $O248*1.5)","=IF(ISBLANK($O248), """", $O248*2.0)","=IF(ISBLANK($O248), """", 4*MIN(10,$O248) + 2*MAX(0,MIN(10,$O248-10)) + 1*MAX(0,$O248-20))","=IF(ISBLANK($O248), """", $O248*30)"
Propylthiouracil (PTU),PO,50–150 mg q8h,q8h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O249), """", $O249*1.0)","=IF(ISBLANK($O249), """", $O249*1.5)","=IF(ISBLANK($O249), """", $O249*2.0)","=IF(ISBLANK($O249), """", 4*MIN(10,$O249) + 2*MAX(0,MIN(10,$O249-10)) + 1*MAX(0,$O249-20))","=IF(ISBLANK($O249), """", $O249*30)"
Fludrocortisone,PO,0.05–0.2 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O250), """", $O250*1.0)","=IF(ISBLANK($O250), """", $O250*1.5)","=IF(ISBLANK($O250), """", $O250*2.0)","=IF(ISBLANK($O250), """", 4*MIN(10,$O250) + 2*MAX(0,MIN(10,$O250-10)) + 1*MAX(0,$O250-20))","=IF(ISBLANK($O250), """", $O250*30)"
Esomeprazole,"IV, PO",40 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O251), """", $O251*1.0)","=IF(ISBLANK($O251), """", $O251*1.5)","=IF(ISBLANK($O251), """", $O251*2.0)","=IF(ISBLANK($O251), """", 4*MIN(10,$O251) + 2*MAX(0,MIN(10,$O251-10)) + 1*MAX(0,$O251-20))","=IF(ISBLANK($O251), """", $O251*30)"
Lansoprazole,PO,30 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O252), """", $O252*1.0)","=IF(ISBLANK($O252), """", $O252*1.5)","=IF(ISBLANK($O252), """", $O252*2.0)","=IF(ISBLANK($O252), """", 4*MIN(10,$O252) + 2*MAX(0,MIN(10,$O252-10)) + 1*MAX(0,$O252-20))","=IF(ISBLANK($O252), """", $O252*30)"
Omeprazole,PO,20–40 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O253), """", $O253*1.0)","=IF(ISBLANK($O253), """", $O253*1.5)","=IF(ISBLANK($O253), """", $O253*2.0)","=IF(ISBLANK($O253), """", 4*MIN(10,$O253) + 2*MAX(0,MIN(10,$O253-10)) + 1*MAX(0,$O253-20))","=IF(ISBLANK($O253), """", $O253*30)"
Sucralfate,PO,1 g QID before meals/HS,QID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O254), """", $O254*1.0)","=IF(ISBLANK($O254), """", $O254*1.5)","=IF(ISBLANK($O254), """", $O254*2.0)","=IF(ISBLANK($O254), """", 4*MIN(10,$O254) + 2*MAX(0,MIN(10,$O254-10)) + 1*MAX(0,$O254-20))","=IF(ISBLANK($O254), """", $O254*30)"
Misoprostol,PO,200 mcg QID,QID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O255), """", $O255*1.0)","=IF(ISBLANK($O255), """", $O255*1.5)","=IF(ISBLANK($O255), """", $O255*2.0)","=IF(ISBLANK($O255), """", 4*MIN(10,$O255) + 2*MAX(0,MIN(10,$O255-10)) + 1*MAX(0,$O255-20))","=IF(ISBLANK($O255), """", $O255*30)"
Promethazine,"IV, PO, PR",12.5–25 mg q6h PRN,q6h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O256), """", $O256*1.0)","=IF(ISBLANK($O256), """", $O256*1.5)","=IF(ISBLANK($O256), """", $O256*2.0)","=IF(ISBLANK($O256), """", 4*MIN(10,$O256) + 2*MAX(0,MIN(10,$O256-10)) + 1*MAX(0,$O256-20))","=IF(ISBLANK($O256), """", $O256*30)"
Meclizine,PO,25–50 mg q24h PRN,q24h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O257), """", $O257*1.0)","=IF(ISBLANK($O257), """", $O257*1.5)","=IF(ISBLANK($O257), """", $O257*2.0)","=IF(ISBLANK($O257), """", 4*MIN(10,$O257) + 2*MAX(0,MIN(10,$O257-10)) + 1*MAX(0,$O257-20))","=IF(ISBLANK($O257), """", $O257*30)"
Scopolamine patch,TD,1 patch q72h,q72h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O258), """", $O258*1.0)","=IF(ISBLANK($O258), """", $O258*1.5)","=IF(ISBLANK($O258), """", $O258*2.0)","=IF(ISBLANK($O258), """", 4*MIN(10,$O258) + 2*MAX(0,MIN(10,$O258-10)) + 1*MAX(0,$O258-20))","=IF(ISBLANK($O258), """", $O258*30)"
Aprepitant,PO,"125 mg day 1, then 80 mg q24h ×2",q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O259), """", $O259*1.0)","=IF(ISBLANK($O259), """", $O259*1.5)","=IF(ISBLANK($O259), """", $O259*2.0)","=IF(ISBLANK($O259), """", 4*MIN(10,$O259) + 2*MAX(0,MIN(10,$O259-10)) + 1*MAX(0,$O259-20))","=IF(ISBLANK($O259), """", $O259*30)"
Palonosetron,IV,0.25 mg IV once,Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O260), """", $O260*1.0)","=IF(ISBLANK($O260), """", $O260*1.5)","=IF(ISBLANK($O260), """", $O260*2.0)","=IF(ISBLANK($O260), """", 4*MIN(10,$O260) + 2*MAX(0,MIN(10,$O260-10)) + 1*MAX(0,$O260-20))","=IF(ISBLANK($O260), """", $O260*30)"
Loperamide,PO,4 mg then 2 mg after each stool (max 16 mg/day),PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O261), """", $O261*1.0)","=IF(ISBLANK($O261), """", $O261*1.5)","=IF(ISBLANK($O261), """", $O261*2.0)","=IF(ISBLANK($O261), """", 4*MIN(10,$O261) + 2*MAX(0,MIN(10,$O261-10)) + 1*MAX(0,$O261-20))","=IF(ISBLANK($O261), """", $O261*30)"
Diphenoxylate-atropine,PO,2 tabs QID then reduce,QID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O262), """", $O262*1.0)","=IF(ISBLANK($O262), """", $O262*1.5)","=IF(ISBLANK($O262), """", $O262*2.0)","=IF(ISBLANK($O262), """", 4*MIN(10,$O262) + 2*MAX(0,MIN(10,$O262-10)) + 1*MAX(0,$O262-20))","=IF(ISBLANK($O262), """", $O262*30)"
Pancrelipase,PO,Per lipase units with meals,TID with meals,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O263), """", $O263*1.0)","=IF(ISBLANK($O263), """", $O263*1.5)","=IF(ISBLANK($O263), """", $O263*2.0)","=IF(ISBLANK($O263), """", 4*MIN(10,$O263) + 2*MAX(0,MIN(10,$O263-10)) + 1*MAX(0,$O263-20))","=IF(ISBLANK($O263), """", $O263*30)"
Ursodiol,PO,300 mg BID,BID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O264), """", $O264*1.0)","=IF(ISBLANK($O264), """", $O264*1.5)","=IF(ISBLANK($O264), """", $O264*2.0)","=IF(ISBLANK($O264), """", 4*MIN(10,$O264) + 2*MAX(0,MIN(10,$O264-10)) + 1*MAX(0,$O264-20))","=IF(ISBLANK($O264), """", $O264*30)"
Tramadol,PO,25–50 mg q6h PRN (max 400 mg/day),q6h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O265), """", $O265*1.0)","=IF(ISBLANK($O265), """", $O265*1.5)","=IF(ISBLANK($O265), """", $O265*2.0)","=IF(ISBLANK($O265), """", 4*MIN(10,$O265) + 2*MAX(0,MIN(10,$O265-10)) + 1*MAX(0,$O265-20))","=IF(ISBLANK($O265), """", $O265*30)"
Methadone,PO,2.5–10 mg q8–12h (opioid-tolerant protocols),q8–12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O266), """", $O266*1.0)","=IF(ISBLANK($O266), """", $O266*1.5)","=IF(ISBLANK($O266), """", $O266*2.0)","=IF(ISBLANK($O266), """", 4*MIN(10,$O266) + 2*MAX(0,MIN(10,$O266-10)) + 1*MAX(0,$O266-20))","=IF(ISBLANK($O266), """", $O266*30)"
Buprenorphine/naloxone (SL),SL,2–8 mg SL q12–24h (induction protocols),q12–24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O267), """", $O267*1.0)","=IF(ISBLANK($O267), """", $O267*1.5)","=IF(ISBLANK($O267), """", $O267*2.0)","=IF(ISBLANK($O267), """", 4*MIN(10,$O267) + 2*MAX(0,MIN(10,$O267-10)) + 1*MAX(0,$O267-20))","=IF(ISBLANK($O267), """", $O267*30)"
Ketamine (analgesic infusion),IV,0.1–0.3 mg/kg/h,Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O268), """", $O268*1.0)","=IF(ISBLANK($O268), """", $O268*1.5)","=IF(ISBLANK($O268), """", $O268*2.0)","=IF(ISBLANK($O268), """", 4*MIN(10,$O268) + 2*MAX(0,MIN(10,$O268-10)) + 1*MAX(0,$O268-20))","=IF(ISBLANK($O268), """", $O268*30)"
Lidocaine 5% patch,TD,Apply up to 12 h/day (max 3 patches),Daily,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O269), """", $O269*1.0)","=IF(ISBLANK($O269), """", $O269*1.5)","=IF(ISBLANK($O269), """", $O269*2.0)","=IF(ISBLANK($O269), """", 4*MIN(10,$O269) + 2*MAX(0,MIN(10,$O269-10)) + 1*MAX(0,$O269-20))","=IF(ISBLANK($O269), """", $O269*30)"
Topical diclofenac 1% gel,Topical,2–4 g QID over affected area,QID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O270), """", $O270*1.0)","=IF(ISBLANK($O270), """", $O270*1.5)","=IF(ISBLANK($O270), """", $O270*2.0)","=IF(ISBLANK($O270), """", 4*MIN(10,$O270) + 2*MAX(0,MIN(10,$O270-10)) + 1*MAX(0,$O270-20))","=IF(ISBLANK($O270), """", $O270*30)"
Midazolam,IV,1–5 mg IV PRN; infusion per sedation,PRN/infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O271), """", $O271*1.0)","=IF(ISBLANK($O271), """", $O271*1.5)","=IF(ISBLANK($O271), """", $O271*2.0)","=IF(ISBLANK($O271), """", 4*MIN(10,$O271) + 2*MAX(0,MIN(10,$O271-10)) + 1*MAX(0,$O271-20))","=IF(ISBLANK($O271), """", $O271*30)"
Etomidate,IV,0.2–0.3 mg/kg IV (induction),Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O272), """", $O272*1.0)","=IF(ISBLANK($O272), """", $O272*1.5)","=IF(ISBLANK($O272), """", $O272*2.0)","=IF(ISBLANK($O272), """", 4*MIN(10,$O272) + 2*MAX(0,MIN(10,$O272-10)) + 1*MAX(0,$O272-20))","=IF(ISBLANK($O272), """", $O272*30)"
Rocuronium,IV,0.6–1.2 mg/kg IV (RSI),Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O273), """", $O273*1.0)","=IF(ISBLANK($O273), """", $O273*1.5)","=IF(ISBLANK($O273), """", $O273*2.0)","=IF(ISBLANK($O273), """", 4*MIN(10,$O273) + 2*MAX(0,MIN(10,$O273-10)) + 1*MAX(0,$O273-20))","=IF(ISBLANK($O273), """", $O273*30)"
Succinylcholine,IV,1–1.5 mg/kg IV (RSI),Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O274), """", $O274*1.0)","=IF(ISBLANK($O274), """", $O274*1.5)","=IF(ISBLANK($O274), """", $O274*2.0)","=IF(ISBLANK($O274), """", 4*MIN(10,$O274) + 2*MAX(0,MIN(10,$O274-10)) + 1*MAX(0,$O274-20))","=IF(ISBLANK($O274), """", $O274*30)"
Cisatracurium,IV,0.1–0.2 mg/kg bolus; 1–3 mcg/kg/min infusion,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O275), """", $O275*1.0)","=IF(ISBLANK($O275), """", $O275*1.5)","=IF(ISBLANK($O275), """", $O275*2.0)","=IF(ISBLANK($O275), """", 4*MIN(10,$O275) + 2*MAX(0,MIN(10,$O275-10)) + 1*MAX(0,$O275-20))","=IF(ISBLANK($O275), """", $O275*30)"
Sertraline,PO,25–100 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O276), """", $O276*1.0)","=IF(ISBLANK($O276), """", $O276*1.5)","=IF(ISBLANK($O276), """", $O276*2.0)","=IF(ISBLANK($O276), """", 4*MIN(10,$O276) + 2*MAX(0,MIN(10,$O276-10)) + 1*MAX(0,$O276-20))","=IF(ISBLANK($O276), """", $O276*30)"
Citalopram,PO,10–40 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O277), """", $O277*1.0)","=IF(ISBLANK($O277), """", $O277*1.5)","=IF(ISBLANK($O277), """", $O277*2.0)","=IF(ISBLANK($O277), """", 4*MIN(10,$O277) + 2*MAX(0,MIN(10,$O277-10)) + 1*MAX(0,$O277-20))","=IF(ISBLANK($O277), """", $O277*30)"
Escitalopram,PO,5–20 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O278), """", $O278*1.0)","=IF(ISBLANK($O278), """", $O278*1.5)","=IF(ISBLANK($O278), """", $O278*2.0)","=IF(ISBLANK($O278), """", 4*MIN(10,$O278) + 2*MAX(0,MIN(10,$O278-10)) + 1*MAX(0,$O278-20))","=IF(ISBLANK($O278), """", $O278*30)"
Fluoxetine,PO,10–40 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O279), """", $O279*1.0)","=IF(ISBLANK($O279), """", $O279*1.5)","=IF(ISBLANK($O279), """", $O279*2.0)","=IF(ISBLANK($O279), """", 4*MIN(10,$O279) + 2*MAX(0,MIN(10,$O279-10)) + 1*MAX(0,$O279-20))","=IF(ISBLANK($O279), """", $O279*30)"
Paroxetine,PO,10–40 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O280), """", $O280*1.0)","=IF(ISBLANK($O280), """", $O280*1.5)","=IF(ISBLANK($O280), """", $O280*2.0)","=IF(ISBLANK($O280), """", 4*MIN(10,$O280) + 2*MAX(0,MIN(10,$O280-10)) + 1*MAX(0,$O280-20))","=IF(ISBLANK($O280), """", $O280*30)"
Venlafaxine XR,PO,37.5–225 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O281), """", $O281*1.0)","=IF(ISBLANK($O281), """", $O281*1.5)","=IF(ISBLANK($O281), """", $O281*2.0)","=IF(ISBLANK($O281), """", 4*MIN(10,$O281) + 2*MAX(0,MIN(10,$O281-10)) + 1*MAX(0,$O281-20))","=IF(ISBLANK($O281), """", $O281*30)"
Duloxetine,PO,30–60 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O282), """", $O282*1.0)","=IF(ISBLANK($O282), """", $O282*1.5)","=IF(ISBLANK($O282), """", $O282*2.0)","=IF(ISBLANK($O282), """", 4*MIN(10,$O282) + 2*MAX(0,MIN(10,$O282-10)) + 1*MAX(0,$O282-20))","=IF(ISBLANK($O282), """", $O282*30)"
Mirtazapine,PO,7.5–45 mg HS,HS,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O283), """", $O283*1.0)","=IF(ISBLANK($O283), """", $O283*1.5)","=IF(ISBLANK($O283), """", $O283*2.0)","=IF(ISBLANK($O283), """", 4*MIN(10,$O283) + 2*MAX(0,MIN(10,$O283-10)) + 1*MAX(0,$O283-20))","=IF(ISBLANK($O283), """", $O283*30)"
Bupropion SR,PO,150 mg q12h (avoid seizures/ETOH withdrawal),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O284), """", $O284*1.0)","=IF(ISBLANK($O284), """", $O284*1.5)","=IF(ISBLANK($O284), """", $O284*2.0)","=IF(ISBLANK($O284), """", 4*MIN(10,$O284) + 2*MAX(0,MIN(10,$O284-10)) + 1*MAX(0,$O284-20))","=IF(ISBLANK($O284), """", $O284*30)"
Hydroxyzine,PO,25–50 mg q6h PRN anxiety,q6h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O285), """", $O285*1.0)","=IF(ISBLANK($O285), """", $O285*1.5)","=IF(ISBLANK($O285), """", $O285*2.0)","=IF(ISBLANK($O285), """", 4*MIN(10,$O285) + 2*MAX(0,MIN(10,$O285-10)) + 1*MAX(0,$O285-20))","=IF(ISBLANK($O285), """", $O285*30)"
Risperidone,"PO, ODT",0.5–2 mg q12–24h,q12–24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O286), """", $O286*1.0)","=IF(ISBLANK($O286), """", $O286*1.5)","=IF(ISBLANK($O286), """", $O286*2.0)","=IF(ISBLANK($O286), """", 4*MIN(10,$O286) + 2*MAX(0,MIN(10,$O286-10)) + 1*MAX(0,$O286-20))","=IF(ISBLANK($O286), """", $O286*30)"
Ziprasidone (IM),IM,10–20 mg IM q2–4h (max 40 mg/day),PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O287), """", $O287*1.0)","=IF(ISBLANK($O287), """", $O287*1.5)","=IF(ISBLANK($O287), """", $O287*2.0)","=IF(ISBLANK($O287), """", 4*MIN(10,$O287) + 2*MAX(0,MIN(10,$O287-10)) + 1*MAX(0,$O287-20))","=IF(ISBLANK($O287), """", $O287*30)"
Aripiprazole,PO,5–15 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O288), """", $O288*1.0)","=IF(ISBLANK($O288), """", $O288*1.5)","=IF(ISBLANK($O288), """", $O288*2.0)","=IF(ISBLANK($O288), """", 4*MIN(10,$O288) + 2*MAX(0,MIN(10,$O288-10)) + 1*MAX(0,$O288-20))","=IF(ISBLANK($O288), """", $O288*30)"
Paliperidone,PO,3–9 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O289), """", $O289*1.0)","=IF(ISBLANK($O289), """", $O289*1.5)","=IF(ISBLANK($O289), """", $O289*2.0)","=IF(ISBLANK($O289), """", 4*MIN(10,$O289) + 2*MAX(0,MIN(10,$O289-10)) + 1*MAX(0,$O289-20))","=IF(ISBLANK($O289), """", $O289*30)"
Lithium carbonate,PO,300 mg q8–12h (titrate to level),q8–12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O290), """", $O290*1.0)","=IF(ISBLANK($O290), """", $O290*1.5)","=IF(ISBLANK($O290), """", $O290*2.0)","=IF(ISBLANK($O290), """", 4*MIN(10,$O290) + 2*MAX(0,MIN(10,$O290-10)) + 1*MAX(0,$O290-20))","=IF(ISBLANK($O290), """", $O290*30)"
Lamotrigine,PO,25 mg daily start; titrate,Daily,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O291), """", $O291*1.0)","=IF(ISBLANK($O291), """", $O291*1.5)","=IF(ISBLANK($O291), """", $O291*2.0)","=IF(ISBLANK($O291), """", 4*MIN(10,$O291) + 2*MAX(0,MIN(10,$O291-10)) + 1*MAX(0,$O291-20))","=IF(ISBLANK($O291), """", $O291*30)"
Phenobarbital,"IV, PO",Load 10–20 mg/kg; maintenance 1–3 mg/kg/day,q12–24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O292), """", $O292*1.0)","=IF(ISBLANK($O292), """", $O292*1.5)","=IF(ISBLANK($O292), """", $O292*2.0)","=IF(ISBLANK($O292), """", 4*MIN(10,$O292) + 2*MAX(0,MIN(10,$O292-10)) + 1*MAX(0,$O292-20))","=IF(ISBLANK($O292), """", $O292*30)"
Clonazepam,PO,0.5–2 mg q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O293), """", $O293*1.0)","=IF(ISBLANK($O293), """", $O293*1.5)","=IF(ISBLANK($O293), """", $O293*2.0)","=IF(ISBLANK($O293), """", 4*MIN(10,$O293) + 2*MAX(0,MIN(10,$O293-10)) + 1*MAX(0,$O293-20))","=IF(ISBLANK($O293), """", $O293*30)"
Nimodipine,PO,60 mg q4h (SAH),q4h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O294), """", $O294*1.0)","=IF(ISBLANK($O294), """", $O294*1.5)","=IF(ISBLANK($O294), """", $O294*2.0)","=IF(ISBLANK($O294), """", 4*MIN(10,$O294) + 2*MAX(0,MIN(10,$O294-10)) + 1*MAX(0,$O294-20))","=IF(ISBLANK($O294), """", $O294*30)"
Alteplase (tPA),IV,"Stroke: 0.9 mg/kg (10% bolus, 90% infusion 60 min)",Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O295), """", $O295*1.0)","=IF(ISBLANK($O295), """", $O295*1.5)","=IF(ISBLANK($O295), """", $O295*2.0)","=IF(ISBLANK($O295), """", 4*MIN(10,$O295) + 2*MAX(0,MIN(10,$O295-10)) + 1*MAX(0,$O295-20))","=IF(ISBLANK($O295), """", $O295*30)"
Tenecteplase,IV,Weight-based bolus for STEMI/stroke (per protocol),Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O296), """", $O296*1.0)","=IF(ISBLANK($O296), """", $O296*1.5)","=IF(ISBLANK($O296), """", $O296*2.0)","=IF(ISBLANK($O296), """", 4*MIN(10,$O296) + 2*MAX(0,MIN(10,$O296-10)) + 1*MAX(0,$O296-20))","=IF(ISBLANK($O296), """", $O296*30)"
Atovaquone,PO,"1,500 mg q24h with food",q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O297), """", $O297*1.0)","=IF(ISBLANK($O297), """", $O297*1.5)","=IF(ISBLANK($O297), """", $O297*2.0)","=IF(ISBLANK($O297), """", 4*MIN(10,$O297) + 2*MAX(0,MIN(10,$O297-10)) + 1*MAX(0,$O297-20))","=IF(ISBLANK($O297), """", $O297*30)"
Pentamidine (inhaled),INH,300 mg neb monthly,Monthly,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O298), """", $O298*1.0)","=IF(ISBLANK($O298), """", $O298*1.5)","=IF(ISBLANK($O298), """", $O298*2.0)","=IF(ISBLANK($O298), """", 4*MIN(10,$O298) + 2*MAX(0,MIN(10,$O298-10)) + 1*MAX(0,$O298-20))","=IF(ISBLANK($O298), """", $O298*30)"
IVIG,IV,0.4 g/kg/day ×5 or 1–2 g/kg total (indication-based),Protocol,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O299), """", $O299*1.0)","=IF(ISBLANK($O299), """", $O299*1.5)","=IF(ISBLANK($O299), """", $O299*2.0)","=IF(ISBLANK($O299), """", 4*MIN(10,$O299) + 2*MAX(0,MIN(10,$O299-10)) + 1*MAX(0,$O299-20))","=IF(ISBLANK($O299), """", $O299*30)"
Epoetin alfa,"SC, IV",50–100 units/kg TIW,TIW,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O300), """", $O300*1.0)","=IF(ISBLANK($O300), """", $O300*1.5)","=IF(ISBLANK($O300), """", $O300*2.0)","=IF(ISBLANK($O300), """", 4*MIN(10,$O300) + 2*MAX(0,MIN(10,$O300-10)) + 1*MAX(0,$O300-20))","=IF(ISBLANK($O300), """", $O300*30)"
Darbepoetin alfa,"SC, IV",0.45 mcg/kg weekly or 0.75 mcg/kg q2wk,Weekly–q2wk,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O301), """", $O301*1.0)","=IF(ISBLANK($O301), """", $O301*1.5)","=IF(ISBLANK($O301), """", $O301*2.0)","=IF(ISBLANK($O301), """", 4*MIN(10,$O301) + 2*MAX(0,MIN(10,$O301-10)) + 1*MAX(0,$O301-20))","=IF(ISBLANK($O301), """", $O301*30)"
Tacrolimus,"PO, IV",PO 0.05–0.1 mg/kg/day divided; IV 0.01 mg/kg/day,q12h/continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O302), """", $O302*1.0)","=IF(ISBLANK($O302), """", $O302*1.5)","=IF(ISBLANK($O302), """", $O302*2.0)","=IF(ISBLANK($O302), """", 4*MIN(10,$O302) + 2*MAX(0,MIN(10,$O302-10)) + 1*MAX(0,$O302-20))","=IF(ISBLANK($O302), """", $O302*30)"
Mycophenolate mofetil,"PO, IV",1 g PO/IV q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O303), """", $O303*1.0)","=IF(ISBLANK($O303), """", $O303*1.5)","=IF(ISBLANK($O303), """", $O303*2.0)","=IF(ISBLANK($O303), """", 4*MIN(10,$O303) + 2*MAX(0,MIN(10,$O303-10)) + 1*MAX(0,$O303-20))","=IF(ISBLANK($O303), """", $O303*30)"
Prednisone (chronic),PO,5–20 mg q24h (taper per regimen),q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O304), """", $O304*1.0)","=IF(ISBLANK($O304), """", $O304*1.5)","=IF(ISBLANK($O304), """", $O304*2.0)","=IF(ISBLANK($O304), """", 4*MIN(10,$O304) + 2*MAX(0,MIN(10,$O304-10)) + 1*MAX(0,$O304-20))","=IF(ISBLANK($O304), """", $O304*30)"
Baclofen,PO,5–20 mg q8h,q8h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O305), """", $O305*1.0)","=IF(ISBLANK($O305), """", $O305*1.5)","=IF(ISBLANK($O305), """", $O305*2.0)","=IF(ISBLANK($O305), """", 4*MIN(10,$O305) + 2*MAX(0,MIN(10,$O305-10)) + 1*MAX(0,$O305-20))","=IF(ISBLANK($O305), """", $O305*30)"
Dicyclomine,PO,10–20 mg q6h,q6h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O306), """", $O306*1.0)","=IF(ISBLANK($O306), """", $O306*1.5)","=IF(ISBLANK($O306), """", $O306*2.0)","=IF(ISBLANK($O306), """", 4*MIN(10,$O306) + 2*MAX(0,MIN(10,$O306-10)) + 1*MAX(0,$O306-20))","=IF(ISBLANK($O306), """", $O306*30)"
Clonidine,"PO, TD",0.1–0.3 mg PO q8–12h; patch 0.1–0.3 mg/24h weekly,q8–12h/weekly,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O307), """", $O307*1.0)","=IF(ISBLANK($O307), """", $O307*1.5)","=IF(ISBLANK($O307), """", $O307*2.0)","=IF(ISBLANK($O307), """", 4*MIN(10,$O307) + 2*MAX(0,MIN(10,$O307-10)) + 1*MAX(0,$O307-20))","=IF(ISBLANK($O307), """", $O307*30)"
Propranolol,"PO, IV",10–40 mg PO q6–8h; IV 1 mg q2–5 min to 3 mg,q6–8h/PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O308), """", $O308*1.0)","=IF(ISBLANK($O308), """", $O308*1.5)","=IF(ISBLANK($O308), """", $O308*2.0)","=IF(ISBLANK($O308), """", 4*MIN(10,$O308) + 2*MAX(0,MIN(10,$O308-10)) + 1*MAX(0,$O308-20))","=IF(ISBLANK($O308), """", $O308*30)"
Prochlorperazine (supp),PR,25 mg PR BID PRN,BID PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O309), """", $O309*1.0)","=IF(ISBLANK($O309), """", $O309*1.5)","=IF(ISBLANK($O309), """", $O309*2.0)","=IF(ISBLANK($O309), """", 4*MIN(10,$O309) + 2*MAX(0,MIN(10,$O309-10)) + 1*MAX(0,$O309-20))","=IF(ISBLANK($O309), """", $O309*30)"
Ketamine (procedural),IV,1–2 mg/kg IV bolus (sedation),Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O310), """", $O310*1.0)","=IF(ISBLANK($O310), """", $O310*1.5)","=IF(ISBLANK($O310), """", $O310*2.0)","=IF(ISBLANK($O310), """", 4*MIN(10,$O310) + 2*MAX(0,MIN(10,$O310-10)) + 1*MAX(0,$O310-20))","=IF(ISBLANK($O310), """", $O310*30)"
Sodium acetate (IV),IV,As component of custom fluids,Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,"=IF(ISBLANK($O311), """", $O311*1.0)","=IF(ISBLANK($O311), """", $O311*1.5)","=IF(ISBLANK($O311), """", $O311*2.0)","=IF(ISBLANK($O311), """", 4*MIN(10,$O311) + 2*MAX(0,MIN(10,$O311-10)) + 1*MAX(0,$O311-20))","=IF(ISBLANK($O311), """", $O311*30)"
Terazosin,PO,1–10 mg HS,HS,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Doxazosin,PO,1–8 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Carvedilol (PO),PO,6.25–25 mg q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Spironolactone (HF),PO,12.5–50 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Eplerenone,PO,25–50 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Clopidogrel (load),PO,300–600 mg once then 75 mg q24h,Once/then daily,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Aspirin (rectal),PR,300 mg PR once then 81 mg PO q24h,Once/then daily,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Heparin (ACS bolus),IV,60–70 U/kg IV then infusion per protocol,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Tranexamic acid,IV,1 g IV over 10 min then 1 g over 8 h,Protocol,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Desmopressin (bleed),IV,0.3 mcg/kg IV over 30 min,Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Prothrombin complex concentrate (4F-PCC),IV,25–50 U/kg per INR,Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Vitamin K (phytonadione),"IV, PO",2.5–10 mg IV/PO,Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Idarucizumab,IV,5 g IV (2×2.5 g) for dabigatran reversal,Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Andexanet alfa,IV,Dose per last rivaroxaban/apixaban dose,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Protamine,IV,1 mg per 100 U heparin given in prior 2–3 h,Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Norethindrone (AUB),PO,5–10 mg TID (short course),TID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Medroxyprogesterone (AUB),PO,10 mg q12h (short course),q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Oxytocin (PPH),IV,10–40 units in 1 L; titrate,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Misoprostol (PPH),"PO, PR","600–1,000 mcg once",Once,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Methylergonovine,IM,0.2 mg IM q2–4h PRN,PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Carboprost,IM,250 mcg IM q15–90min (max 2 mg),PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Magnesium sulfate (OB),IV,4–6 g load then 1–2 g/h,Infusion,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Nifedipine (IR),PO,10 mg q6–8h PRN HTN,q6–8h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Nicotine patch,TD,21 mg/24h then taper,Daily,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Nicotine gum/lozenge,PO,2–4 mg q1–2h PRN,PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Varenicline,PO,0.5 mg daily ×3 then 0.5 mg BID ×4 then 1 mg BID,BID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Benzonatate,PO,100–200 mg TID PRN,TID PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Codeine-guaifenesin,PO,5–10 mL q4–6h PRN,q4–6h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Montelukast (night),PO,10 mg HS,HS,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Ipratropium-albuterol MDI,INH,1 puff q6h,q6h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Revefenacin (neb),INH,175 mcg neb q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Arformoterol (neb),INH,15 mcg neb q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Glycopyrrolate (neb),INH,25 mcg neb q12h,q12h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Sodium bicarbonate infusion,IV,"D5W + NaHCO3 per protocol (e.g., 150 mEq/L)",Continuous,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Hypertonic saline 3% (IV),IV,30–100 mL/h or bolus 2–3 mL/kg,Continuous/bolus,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Mannitol (ICP),IV,0.25–1 g/kg q6–8h PRN,q6–8h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
N-acetylcysteine (PO),PO,140 mg/kg load then 70 mg/kg q4h ×17,q4h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Thiamine (high-dose),IV,200–500 mg IV TID (Wernicke),TID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Folic acid (high-risk),"IV, PO",1–5 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Pyridoxine (B6),"IV, PO","50–100 mg q24h (INH tox, hyperemesis)",q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Cyanocobalamin (defic.),IM,"1,000 mcg IM daily ×1wk, weekly ×1mo, monthly",Varies,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Iron sucrose (IV),IV,200 mg IV on 5 doses (or per protocol),Intermittent,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Ferric carboxymaltose (IV),IV,750 mg IV ×2 doses 7+ days apart,Intermittent,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Sodium phosphate enema,PR,1 enema PR PRN,PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
SMOG enema,PR,Per protocol once PRN,PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Lubiprostone,PO,24 mcg BID,BID,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Prucalopride,PO,2 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Diphenhydramine (sleep),PO,25–50 mg HS PRN,HS PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Doxepin (sleep),PO,3–6 mg HS,HS,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Quetiapine (sleep),PO,25–50 mg HS PRN,HS PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Clonidine (sleep),PO,0.1 mg HS PRN,HS PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Haloperidol (delirium),IV,0.5–2 mg IV q4–6h PRN,q4–6h PRN,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
Olanzapine ODT,PO,5–10 mg q24h,q24h,—,—,—,—,Check CrCl/eGFR; adjust dose/interval where applicable; post-HD dosing if dialyzable,Use Child-Pugh guidance; reduce/avoid in severe impairment; monitor LFTs,,,,,,,,,,
